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The development of multicellular organisms requires a tight coordination of 
cell proliferation, cell differentiation and cell death in order to correctly 
specify cell fate and number.  According to the trophic theory of survival, 
this is achieved in part by a competition between cells in a tissue for a 
limited number of extracellular survival factors.  Cells that do not receive 
sufficient quantities of these survival cues engage a default cell death 
program and are thereby eliminated.  This ‘social control’ of cell survival 
ensures the integrity of tissues by matching the correct number of different 
cell types to each other.  Apoptosis is one morphologically distinct, 
genetically programmed form of cell death by which cells in an organism are 
efficiently and rapidly removed.  The proper execution of apoptosis is 
therefore critical to normal development and homeostasis in metazoans and 
defects in the regulation of apoptosis is known to contribute to the etiology 
of several major diseases.  Initial insights into the complex molecular 
networks that regulate apoptosis derived largely from elegant genetic 
analyses of invertebrate model organisms.  These early studies identified 
several genes critical for the execution of the apoptosis and established an 
evolutionarily conserved core cell death pathway.  To further elucidate the 
molecular mechanisms underlying the control of apoptosis, we conducted 
several mutagenesis screens in Drosophila melanogaster to identify genes 
that can modulate cell death phenotypes.  One particularly interesting mutant 
isolated in these screens was recovered as a strong, specific and dominant 
suppressor of cell death induced by the RHG protein hid.  We demonstrate 
that this mutant is a gain-of-function allele of ras85D (ras1), the Drosophila 
homolog of mammalian oncogenes H-ras, K-ras and N-ras.  We further 
establish that this viable allele, rasR68Q, contains a mutation in the Switch II 
region of Ras and that it produces a GTPase protein with diminished 
enzymatic activity.  RasR68Q is the first endogenous gain-of-function ras1 
allele to be identified in Drosophila and represents one of very few 
hypermorphic Ras mutations compatible with organismal viability to be 
isolated. 
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CHAPTER 1. 
 
Introduction 
 
 2 
Programmed Cell Death 
 Animal development encompasses not only cell proliferation, but also 
highly regulated cell death.  Biologists have recognized the occurrence of 
cell death in multicellular organisms as a normal physiological event for 
more than 150 years (Glucksmann, 1951). The term programmed cell death 
(PCD) was first introduced in 1964 following the characterization of 
intersegmental muscle degeneration during pupation in the silkmoth.  Noting 
the “carefully timed” and ecdysone dependent nature of cellular dissolution 
in this organism, the authors posited the concept that cell death during 
development is not of an accidental or random nature, but rather follows a 
sequence of precisely controlled steps that ultimately lead to spatially and 
temporally defined cell deaths (Lockshin and Williams, 1964). 
The manner in which a cell dies can vary tremendously from 
paradigm to paradigm, rendering it difficult to study the general phenomena 
of cell death in a systematic manner.  The framework for scientific inquiry 
into the mechanisms regulating PCD was significantly advanced in 1972 
when the Scottish pathologists Andrew H. Wyllie, John F. Kerr and A.R. 
Currie coined the term “apoptosis” to describe a common and stereotypic 
subset of cell deaths (Kerr et al., 1972).  Apoptosis describes a 
morphologically distinct form of cell death that is accompanied by rounding-
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up of the cell, retraction of pseudopodia, reduction of cellular volume 
(pyknosis), condensation of the chromatin, fragmentation of the nucleus 
(karyorhexis), little or no ultrastructural modification of cytoplasmic 
organelles, plasma membrane blebbing, and maintenance of an intact plasma 
membrane until late stages of the process (Bellairs, 1961; Kroemer et al., 
2005).  Unlike necrosis, which typically occurs as a result of toxic cellular 
insults, apoptosis was observed to occur in a regulated manner as a normal 
part of animal development.  Kerr et al further noted that, in contrast to 
necrosis, cells eliminated by apoptosis were removed rapidly and efficiently 
without eliciting an inflammatory response.  In addition to the above 
morphological criteria, apoptosis has subsequently become associated with a 
number of biochemical changes including loss of membrane phospholipid 
asymmetry, DNA fragmentation, activation of caspases and activation of 
nucleases (Hengartner, 2000). 
It is now appreciated that PCD is an active, gene-directed process 
essential for the proper growth, morphogenesis and homeostasis of 
metazoans.  Apoptosis is used extensively in animal development for the 
removal of unnecessary cells and structures, the sculpting of tissues, the 
adjustment of cell numbers and as a defensive strategy to remove infected, 
mutated, or damaged cells (Jacobson et al., 1997; Vaux and Korsmeyer, 
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1999).  Classic examples of the use of apoptosis in developmental biology 
include; deletion of the tadpole tail during metamorphosis into an adult frog 
(Tata, 1994), formation of free and independent digits by removal of 
interdigital mesenchymal cells during limb pattern formation (Mori et al., 
1995), culling of greater than 50% of neurons by apoptosis during 
maturation of the vertebrate brain (Yuan and Yankner, 2000), and formation 
of vertebrate reproductive organs by deletion of the Wolffian duct in females 
or of the Müllerian duct in males (Meier et al., 2000a).  
Given the integral role of apoptosis in animal development and 
homeostasis, it is perhaps not surprising that defects in the regulation of 
apoptosis can contribute to the etiology of several major diseases.  Excess 
apoptosis is a characteristic of many neurological diseases which exhibit the 
gradual loss of specific sets of neurons, resulting in disorders of movement 
and CNS function (Sastry and Rao, 2000). Diseases for which excess 
apoptosis is believed to play a causal role include Parkinson’s disease, 
amyotrophic lateral sclerosis, retinitis pigmentosa, several forms of 
cerebellar degeneration, spinal muscular atrophy and Alzheimer’s disease 
(Thompson, 1995).  In contrast, a reduction in apoptosis is associated with 
cancer and autoimmunity.  In cancer for example, inappropriate activation of 
the negative regulator of apoptosis, Bcl-2, is associated with non-Hodgkin’s 
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lymphomas (Tsujimoto et al., 1985).  Similarly, inactivation of Bax, a 
positive regulator of cell death, is associated with colon, gastrointestinal and 
hematological malignancies (Meijerink et al., 1995; Rampino et al., 1997; 
Yamamoto et al., 1997). 
Extensive research efforts conducted into the subject of programmed 
cell death over the last two decades have yielded a detailed understanding of 
many of the mechanisms and pathways involved in this vital biological 
phenomenon.  It is now recognized for example, that programmed cell death 
can occur through several diverse mechanisms that lead to a variety of 
distinct cell death morphologies (Kroemer et al., 2005).  In response to this 
greatly improved understanding, a multitude of novel terms have arisen to 
describe these varied types of cell death including, apoptosis, necrosis, 
autophagy (Levine and Klionsky, 2004), mitotic catastrophe (Castedo et al., 
2004), anoikis (Frisch and Screaton, 2001), excitotoxicity (Orrenius et al., 
2003) and cornification (Candi et al., 2005).  Recently, there has been a 
surge of interest in type II or autophagic cell death, which is distinguished 
from apoptosis by a stereotypical degradation of the Golgi apparatus, 
polyribosomes, and endoplasmic reticulum prior to nuclear destruction 
(Bursch et al., 2000; Martin and Baehrecke, 2004).  Apoptosis however, is 
by far the most studied and best understood form of programmed cell death, 
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with publications on the subject surpassing 70000 to date (Yuan and 
Horvitz, 2004). 
The ‘modern era’ of apoptosis research and an exponential leap of 
interest in the field was heralded by the identification of several biochemical 
and genetic processes that govern it.  That programmed cell death is 
genetically controlled was appreciated by the late 1960’s pursuant to the 
demonstration by several labs that the inhibition of protein synthesis could 
prevent cell death (Lockshin, 1969; Makman et al., 1971; Tata, 1966).  It 
was not until 1988 however that the first molecular component of apoptosis, 
Bcl-2, was identified as the product of a gene found to be activated by the 
t(14;18) chromosomal translocation in follicular lymphoma (Adams and 
Cory, 1998; Vaux et al., 1988).  Unlike previously described oncogenes such 
as c-myc or abl which were known to be promoters of cell proliferation, bcl-
2 did not stimulate cell division, but rather prevented cells from dying when 
growth factor was removed.  Hence, in addition to identifying a molecular 
component of the apoptotic mechanism, this discovery established that 
inhibition of cell death could contribute to the development of cancer in 
humans. 
The first direct evidence that a genetic program exists purely for 
physiological cell death came from groundbreaking screens in the model 
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genetic organism Caenorhabditis elegans (C. elegans), a nematode with an 
invariant, lineage-restricted development that renders this organism ideal for 
the genetic study of programmed cell death.  During ontogeny of the adult 
hermaphrodite worm, precisely 131 of the 1,090 somatic cells predictably 
die by apoptosis, leaving an adult comprised of exactly 959 cells of known 
origin (Sulston and Horvitz, 1977; Sulston et al., 1983).  Genetic screens in 
C. elegans subsequently identified three genes, egl-1, ced-4 and ced-3 that 
are essential for the execution of cell death in this organism.  Loss-of-
function mutations in any one of these genes disables the apoptotic program 
and leads to the survival of all somatic cells that normally die by apoptosis 
during wild-type C. elegans development (Conradt and Horvitz, 1998; Ellis 
and Horvitz, 1986).  Conversely, a fourth gene, ced-9, was discovered to be 
absolutely required for protection against unscheduled cell deaths in C. 
elegans since null mutations in ced-9 result in extensive ectopic apoptosis 
during development (Hengartner et al., 1992).  The remarkable power of 
such genetic analyses in C. elegans has led to the identification of more than 
20 genes that function in programmed cell death and has permitted these 
genes to be ordered into a coherent genetic pathway.  For their pioneering 
contributions to developmental genetics and programmed cell death, Sydney 
Brenner, Robert Horvitz and John Sulston received the Nobel Prize in 
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Physiology or Medicine in 2002 (Brenner, 2003; Horvitz, 2003; Sulston, 
2003). 
The independent discovery that human Bcl-2 could prevent 
programmed cell death in C. elegans indicated that apoptosis in mammalian 
cells and programmed cell death in the nematode were highly related 
processes.  This insight rapidly progressed to the wider realization that 
apoptosis is in fact an ancient, evolutionarily conserved phenomenon that 
operates in virtually all multicellular organisms and thereby validated the 
use of genetic models to better understand the apoptotic process in human 
development and disease (Vaux et al., 1992).  These genetic and other 
studies ultimately established that many components of the core apoptotic 
pathway originally described in C. elegans by Horvitz et al. are highly 
conserved amongst animals as diverse as the fly, the mouse and humans 
(Danial and Korsmeyer, 2004). 
 
Discovery of Caspases 
A critical advancement in our understanding of the biochemical 
mechanisms regulating apoptosis came in 1993 with the cloning of ced-3 
and the discovery that it encodes a protein similar to the mammalian 
cysteine protease, interleukin-1B-converting enzyme (ICE) (Yuan et al., 
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1993).  This finding firmly established a role for the cysteine aspartate-
specific proteases (caspases) as cell death effectors and proclaimed the 
discovery of a molecular mechanism for apoptosis in C. elegans.  The 
discovery that ced-3 encodes a cysteine protease was completely unexpected 
and indicated a mechanism of action that had not been anticipated.  
Overexpression studies with the newly cloned protein determined that Ced-3 
could induce the death of mammalian cells in a cell-autonomous fashion and 
suggested that both Ced-3 and mammalian caspases cause cells to die by a 
mechanism more direct than that of a hormone or a transcription factor 
(Miura et al., 1993). 
Since the discovery of their role in apoptosis, expansive efforts have 
focused on the identification of caspases and on the analysis of their 
regulation and biological functions.  Certain caspases, such as ICE (now 
known as caspase-1) had already been long examined for their non-apoptotic 
functions, such as in the regulation of inflammation (Cerretti et al., 1992).  
The regulatory functions of caspases in apoptosis and in a number of other 
biological processes have now also been studied in detail.  Caspases 
constitute a family of cysteine aspartyl specific proteases that are highly 
conserved amongst metazoans and in addition to functioning as central 
regulators of apoptosis,  caspases participate in the regulation and execution 
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of a number of critical cellular processes such as the cell cycle, DNA 
replication, DNA repair, inflammation and differentiation (Fischer et al., 
2003; Kuranaga and Miura, 2007; Thornberry and Lazebnik, 1998). 
There has been a clear evolutionary tendency to increase the number 
of caspases over phylogenetic time, from four in C. elegans to seven in 
Drosophila, ten in mice and eleven to twelve distinct caspases in humans 
(caspase 12 is a pseudogene in whites and is functional in a subset of 
individuals of African descent) (Lamkanfi et al., 2002; Shaham, 1998; Xue 
et al., 2006).  Caspases that participate in apoptosis can be broadly classified 
into the initiator caspase group and the effector caspase group based on 
domain architecture and physiologic function (Fig 1.1).  Initiator caspases 
typically occur in the cytosol as inactive monomers, contain long N-terminal 
prodomains that encode related homotypic oligomerization motifs such as 
the caspase recruitment domain (CARD) or the death effector domain 
(DED) and provide a link between cell signaling and apoptotic execution.  In 
contrast, effector caspases often exist as dimers in their inactive form, 
contain a short prodomain that lacks death domains and are thought to act 
downstream of initiator caspases as the ultimate executors of cell death 
(Degterev et al., 2003; Turk and Stoka, 2007). 
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Fig 1.1.  Domain architecture of caspases in flies, mammals and worm.  
Initiator caspases contain prodomains such the CARD or DED and are 
labeled in blue, whereas executioner caspases lack prodomains and are 
labeled in black.  Those caspases for which a clearly defined role in cell 
death has been demonstrated are labeled in bold.  Drosophila contains 7 
caspases, of which 4 are known to be involved in cell death, Dredd, Dronc, 
Drice and Dcp-1.  In mammals, 7 of the 11 identified caspases participate in 
apoptosis, including the initiator Caspases-2,-8,-9 and -10 and the 
executioner Caspases-3,-6 and -9.  A possible role in cell death for other 
caspases however can not yet be excluded.  Ced-3 behaves as both an 
initiator and executioner caspase.  Approximate sites for proteolytic 
processing of zymogens are indicated by black arrows above Ced-3.  CARD, 
Caspase Recruitment Domain; DED, Death Effector Domain. 
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Like most proteases, caspases are generally synthesized as weakly 
active proenzymes or zymogens consisting of an inhibitory N-terminal 
prodomain, followed by a large and then a small protease subunit.  
Overwhelming structural and biochemical evidence predicts that active 
caspases are obligate heterotetramers composed of two identical catalytic 
units, with each catalytic unit containing one active site.  Currently, all three-
dimensional structures of caspases in their active form reveal that each 
catalytic unit is composed of one large and one small subunit derived from 
the same precursor molecule (Fuentes-Prior and Salvesen, 2004).  Subunits 
are generated by the sequential cleavage of precursors at specific aspartate 
residues delineated by a four-amino acid recognition motif within zones of 
the precursor protein termed the ‘linker regions’. 
These structural observations led to the assumption that caspases are 
activated and therefore regulated by proteolytic cleavage (Shi, 2002).  
Though this has been shown to hold true for the effector class of caspases, 
recent studies have revealed that cleavage is neither required nor sufficient 
for activation of the initiator caspases (Boatright et al., 2003).  Instead, 
activation of initiator caspases is effected by an oligomerization process that 
brings multiple procaspase molecules into close proximity via formation of 
large multiprotein complexes.  Evidence for this ‘induced-proximity’ model 
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of caspase activation comes from well-studied caspase complexes such as 
the apoptosome, the death inducing signaling complex (DISC), the 
PIDDosome and the caspase-1-containing inflammasome (Festjens et al., 
2006).  Activator proteins drive multimerization of initiator caspases via 
homotypic interactions between the death domains found in the long 
prodomains of initiator caspases and those found in the activators.  In C. 
elegans, the CARD containing caspase Ced-3 is activated by its recruitment 
into a complex containing the activator Ced-4, while in Drosophila, the 
CARD containing initiator caspase Dronc is activated via recruitment to an 
oligomeric complex containing the activator Ark/Hac-1, which is 
homologous to Ced-4.  Activation of mammalian DED containing caspase-8 
and CARD containing caspase-9 is similarly mediated by recruitment into 
large multimeric complexes, namely, the DISC and the apoptosome, 
respectively.  The ‘induced-proximity’ model of caspase activation is 
discussed in greater detail in the next section. 
Once activated, caspases target and cleave various proteins in order to 
execute their apoptotic or nonapoptotic functions.  In addition to 
autocleaving within activation complexes, a major target of initiator 
caspases are the effector (downstream) caspases, which in turn mediate the 
cleavage of a large number of cellular substrates.  The execution phase of 
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apoptosis is thought to result from the limited caspase-dependent cleavage of 
hundreds of cellular proteins the sum of which results in the morphology 
characteristic of this form of programmed cell death.  Interestingly, the death 
signals generated by the caspase proteolysis of target proteins are propagated 
in both an upstream and downstream fashion.  For example, downstream 
effector caspases cleave initiator caspases and other upstream signaling 
molecules and in this manner generate positive feedback loops in the caspase 
signaling cascade.  This combination of positive feedback with the 
irreversible nature of caspase cleavage results in a highly efficient molecular 
mechanism for executing cell death that is both rapid and inexorable once 
initiated (Turk, 2006).  The efficacy of the apoptotic program can be 
visualized by time-lapse videomicroscopy, which has demonstrated that 
apoptotic cell death, from initiation to phagocytic removal of cell corpses, 
can be extremely rapid, often being completed in 20 min or less.  This 
rapidity can regularly lead to a substantial underestimation of apoptotic rates 
in many experimental paradigms (Evan et al., 1992). 
Understanding the many discrete and interacting signaling pathways 
mediated by caspases will require identification of the natural substrate 
repertoire for each caspase.  Although more than 280 caspase substrates 
have thus far been identified in humans, it appears that many more apoptotic 
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caspase targets have yet to been revealed, a task complicated by the 
overlapping substrate specificities of multiple caspase family members 
(Fischer et al., 2003).  Recent advances in technology, such as mRNA 
display, have allowed for enhanced identification of natural caspase 
substrates with improved delineation of caspase substrate repertoires and 
should improve our understanding of the molecular pathways underpinning 
programmed cell death (Ju et al., 2007). 
 
Intrinsic Activation of Caspases 
Although there are four caspase-like proteins in C. elegans, Ced-3 is 
the only one that has been shown to be required for apoptosis and in this 
regard, Ced-3 uniquely behaves as both an initiator and executor caspase 
(Ellis and Horvitz, 1986; Shaham, 1998).  Genetic screens and epistasis 
experiments in C. elegans have established that the central and most 
downstream step in the execution of cell death is the activation of Ced-3 and 
that Egl-1, Ced-9 and Ced-4 act as upstream regulators for essentially all 
developmental cell deaths (Shaham and Horvitz, 1996).  In addition to these 
genetic studies, most of the protein complexes that are postulated to be 
involved in the activation of Ced-3 have been crystallized, allowing for a 
detailed mechanistic analysis of apoptosis activation in C. elegans.  These 
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structural and biochemical data demonstrate that initiation of the apoptotic 
cascade is achieved through a series of direct protein-protein interactions.  
According to the ‘induced proximity’ model of caspase activation, active 
Ced-3 is generated by recruitment of several proCed-3 molecules into a 
tetrameric Ced-4 complex (Yan et al., 2005; Yang et al., 1998).  In the 
absence of apoptotic stimuli, Ced-4 is sequestered as an inactive dimer on 
the outer surface of mitochondria by a direct interaction with mitochondria-
bound Ced-9 (Spector et al., 1997; Wu et al., 1997).  In cells destined to die, 
developmental or external cues lead to Egl-1 expression, which binds to and 
induces a conformational change in Ced-9, thereby disrupting the Ced-4-
Ced-9 interaction and discharging Ced-4 from the mitochondrial surface into 
the cytosol (Conradt and Horvitz, 1998).  Once liberated, Ced-4 dimers 
oligomerize into the tetrameric complex to which proCed-3 molecules are 
recruited, cleaved and activated (del Peso et al., 1998). 
Despite a disparity in many of the details, several components and 
functional aspects of this core C. elegans pathway are evolutionarily 
conserved in flies and mammals as part of the intrinsic or mitochondrial 
pathway of caspase activation.  In mammals, a member of the initiator 
caspase family, caspase-9, is a critical mediator of the intrinsic apoptotic 
pathway (Hakem et al., 1998; Kuida et al., 1998).  Likewise in Drosophila, 
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the initiator caspase Dronc is required for virtually all programmed cell 
death during embryogenesis (Chew et al., 2004; Daish et al., 2004).  Ced-4, 
an adaptor protein of the P-loop ATPase family, is homologous to 
mammalian apoptotic protease-activating factor-1 (Apaf-1) and Drosophila 
Ark/Hac-1.  These adaptor proteins contain a CARD followed by a 
nucleotide-binding/oligomerization domain and directly bind the CARD of 
initiator caspases to mediate apoptosome formation and caspase activation.  
Ced-9 is an anti-apoptotic member of the Bcl-2 family of proteins, 
containing four Bcl-2 homology (BH) domains and sharing homology with 
several mammalian Bcl-2 family proteins that regulate apoptosis at the level 
of the mitochondria (Danial and Korsmeyer, 2004; Hengartner and Horvitz, 
1994).  Finally, Egl-1 is a pro-apoptotic BH3-only protein that again shares 
significant homology with several mammalian apoptotic regulators (Cory et 
al., 2003).  In Drosophila, the multidomain Bcl-2 family members Debcl 
and Buffy have been shown to localize to mitochondrial and ER membranes 
respectively and to have pro- and anti-apoptotic effects in certain contexts, 
however evidence for their role in the regulation of apoptosis remains 
limited (Doumanis et al., 2007; Igaki et al., 2000; Igaki and Miura, 2004; 
Quinn et al., 2003).  In any event, the study of apoptosis in C. elegans has 
clearly been instrumental in the identification of several key components of 
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an apoptotic cascade that is now known to be highly conserved throughout 
evolution. 
It is equally evident however, that distinct mechanisms and modalities 
of control over caspase activity have evolved amongst various organisms, 
typically with an increasingly complex network of regulators being utilized 
over phylogenetic time.  The C. elegans genome, for example, encodes only 
three Bcl-2 family members (ced-9, ced-13 and egl-1) whereas mammals 
possess a panoply of more than 20 (Cory et al., 2003).  One apparent 
difference between species in the regulation of caspase dependent cell death 
concerns the role of mitochondria and their release of apoptogenic 
intermembrane space proteins.  In mammals, mitochondria have been well 
substantiated as a critical control point for apoptosis induction, regulating 
death signals via a mitochondrial outer membrane permeabilization event 
that discharges into the cytosol several putative pro-apoptotic factors 
including cytochrome c, SMAC/Diablo, Omi/HTRA2, endonuclease G, 
apoptosis inducing factor (AIF) and ARTS (Green and Kroemer, 2004; 
Larisch et al., 2000; Wang, 2001).  The various pro- and anti-apoptotic Bcl-2 
family members in turn regulate this critical permeabilization event through 
mechanisms that remain controversial. 
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Perhaps the best studied role for mitochondria in the regulation of 
mammalian apoptosis concerns the release of cytochrome c.  Upon its 
discharge from mitochondria into the cytoplasm during a permeabilization 
event, cytochrome c binds to the WD40 repeats of Apaf-1, inducing a 
conformational change in Apaf-1 that permits its oligomerization with and 
subsequent activation of Caspase-9 (Li et al., 1997).  This is in marked 
contrast to Ced-4 in C. elegans, which lacks a WD40 domain and does not 
require cytochrome c for its activity in vitro (Yan et al., 2005).  Likewise in 
Drosophila, biochemical and structural evidence to support a role for either 
mitochondria or cytochrome c in Ark/Hac-1 dependent cell death has not 
been forthcoming despite the fact that Ark/Hac-1 does contain C-terminal 
WD40 repeats and is able to bind cytochrome c (Yu et al., 2006).  However, 
recent genetic data from both C. elegans and Drosophila does support at 
least some role for mitochondria in caspase dependent cell death in these 
organisms.  Two mitochondrial proteins, CPS-6 and WAH-1, which are the 
C. elegans homologues of mammalian endonuclease G and AIF 
respectively, are released from mitochondria during apoptotic stimuli and 
synergize to promote DNA degradation (Parrish et al., 2001; Wang et al., 
2002).  In Drosophila, a homolog of the mitochondrial serine protease 
Omi/HTRA2 was recently cloned and shown to efficiently promote cell 
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death in a manner analogous to its mammalian counterpart (Igaki et al., 
2007).  Additional in vivo evidence from Drosophila indicates that a 
particular form of cytochrome c, cyt-c-d, is required for caspase activation 
during spermatid differentiation and for the proper regulation of 
developmental apoptosis in the pupal eye (Arama et al., 2006; Mendes et al., 
2006).  Mitochondrial disruption, which is a conserved aspect of apoptosis 
involving the mitochondrial fission mediator Drp1, has been observed in 
both C. elegans and Drosophila and has been found to affect programmed 
cell death (Goyal et al., 2007; Jagasia et al., 2005).  Finally, there is evidence 
that the Drosophila cell death inducers rpr, hid and grim (the so called RHG 
proteins - see below) require mitochondrial localization via a mitochondrial 
targeting sequence referred to as the GH3 domain for full apoptotic activity 
(Freel et al., 2008). 
 
Extrinsic Activation of Caspases 
A major point of divergence between C. elegans and higher organisms 
in the regulation of caspases relates to the evolution in the latter of a second, 
alternative pathway for caspase activation.  This pathway, referred to as the 
extrinsic cell death pathway, is mediated by transmembrane death receptors 
of the tumor necrosis factor receptor (TNFR) superfamily.  In mammals this 
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includes Fas/CD95/Apo1, TNF-R1, TNF-R2, DR3/WSL-1/TRAMP, 
DR4/TRAIL-R1, DR5/TRAIL-R2, and DR6, all of which are characterized 
by the presence of a cytoplasmic death domain (DD).  Activation of this 
pathway is initiated by ligand-induced receptor trimerization when members 
of the TNF superfamily of ligands, either soluble or membrane bound, bind 
their cognate death receptors.  The recruitment and activation of initiator 
caspases is subsequently achieved by adapter molecules that bridge activated 
death receptors to initiator procaspases via homophilic death domain and 
death effector domain (DED) contacts (Ho and Hawkins, 2005; Park et al., 
2007).  Fas, upon ligand stimulation by FasL, recruits the adapter protein 
FADD to its cytoplasmic tail via a homotypic DD:DD interface.  FADD in 
turn recruits caspase-8 or caspase-10, via homotypic interactions with the 
tandem DED motifs found within the prodomain of these caspases,  to 
generate the ternary death-inducing signaling complex (DISC).   In the case 
of TNFR1 activation by TNF-α, the multifunctional adapter protein TRADD 
is first recruited to the activated receptor again via a DD interaction.  
TRADD in turn engages receptor-interacting protein (RIP) and the TNF 
receptor-associated factors (TRAFs) to form the membrane-bound ‘complex 
I’, essential for IKK and NF-κB activation.  Subsequently, TRADD 
dissociates from TNFR1 and associates with FADD and caspase-8 to 
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generate the cytoplasmic ‘complex II’, a platform for caspase activation.  
The regulated assembly of these two different TRADD complexes may 
underlie the ability of TNF to induce either cell death or cell survival under 
different cellular contexts (Micheau and Tschopp, 2003b).  Ultimately, 
recruitment of procaspases into these high molecular mass complexes 
induces the proteolytic autoprocessing of zymogens via an induced-
proximity mechanism similar to that described for the apoptosome.  This 
liberates active caspase-8  or caspase-10 into the cytoplasm to cleave and 
activate downstream effector caspases such as caspase-3 and caspase-7, 
generating a caspase signaling cascade.  Induction of apoptosis via the 
extrinsic pathway is used extensively in cells of the immune system to 
eliminate immune effector cells that have fulfilled their function and defects 
in components of this pathway manifest as an autoimmune 
lymphoproliferative syndrome (ALPS) (Rieux-Laucat et al., 2003).  
Additionally, mutations in caspase-8 have been linked to a variety of human 
cancers, suggesting that caspases-8 can act as a tumor suppressor. 
 The fly genome clearly encodes an ortholog of FADD, designated 
dFADD, that like its mammalian counterpart, binds to and activates an 
apical caspase, Dredd (Hu and Yang, 2000).  Also encoded by the 
Drosophila genome are two TRAF homologs, dTRAF1 and dTRAF2, a 
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single TNF ligand, Eiger and a single putative TNFR homolog, Wengen, 
which contains an extracellular TNFR homology domain but lacks the 
intracellular DD motif characteristic of the death receptor family (Igaki et 
al., 2002; Kanda et al., 2002; Liu et al., 1999).  Despite the expression of this 
TNF-like axis in Drosophila however, current evidence argues that it 
probably does not engage the dFADD/Dredd module to launch an apoptotic 
caspase cascade.  Instead, the dFADD/Dredd module predominantly 
regulates innate immune responses triggered by Gram negative bacteria 
(Tanji and Ip, 2005).  Nevertheless, Eiger is a potent inducer of apoptosis 
and represents the first TNF cytokine superfamily ligand to be isolated in an 
invertebrate.  Originally identified in a gain-of-function screen for inducers 
of apoptosis, Eiger is a type II transmembrane protein with a C-terminal 
TNF homology domain, is predominantly expressed in the nervous system, 
and can be cleaved and released from the cell surface as a soluble factor.  
Genetic analysis of Eiger mutants revealed that the apoptotic effect of Eiger 
does not require the activity of dFADD/Dredd, but instead is completely 
dependent upon on its ability to activate the Jun-N-terminal kinase (JNK) 
pathway.  Precisely how Eiger achieves activation of JNK and the role of 
Wengen in this pathway remains controversial.  Recent evidence suggests 
that dTRAF2, the Drosophila homolog of the human tumor suppressor and 
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deubiquitinating enzyme CYLD, dCYLD, and the ubiquitination activity of 
Diap1, all play a critical role in transduction and modulation of the Eiger 
signal (Xue et al., 2007).  It seems clear from an phylogenetic perspective 
that the extrinsic pathway of apoptosis induction represents a relatively 
recent evolutionary event, largely confined to mammals, whereas the 
intrinsic pathway is the more ancient, evolutionarily conserved mechanism 
of caspase activation. 
 
Discovery of the RHG Proteins 
Another pointed example of how evolution has led to the emphasis of 
discrete regulatory points of control over the execution of programmed cell 
death was imparted by the discovery in Drosophila of a novel class of 
apoptotic regulatory proteins referred to as the RHG proteins.  D. 
melanogaster has proven an excellent model in which to examine 
programmed cell death, with many advantages, including a well documented 
developmental plasticity, a rapid life cycle, sophisticated genetic tools, well-
developed misexpression systems, a largely complete and annotated genome 
sequence and a wealth of current and historical research literature.  
Furthermore, multiple tissues undergo programmed cell death in a globally 
patterned yet dynamically stochastic manner throughout Drosophila 
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development, affording the opportunity to analyze the complex regulatory 
decisions that control these cell deaths.  Cell death has been characterized in 
the Drosophila embryonic central nervous system, embryonic head region, 
embryonic epidermis, larval salivary glands, larval midgut, larval wing and 
eye imaginal discs, pupal retina, adult nervous system and adult female germ 
line (Gorski and Marra, 2002).  Drosophila was propelled to the forefront of 
apoptosis research in 1994 when a deficiency screen conducted using the 
vital dye Acridine Orange, a marker of dying cells, identified a chromosomal 
region essential for virtually all embryonic cell deaths, as well as ectopic 
deaths induced by irradiation and developmental defects (White et al., 1994).  
Subsequent analysis of this region, spanning 75C1-2 and deleted in the H99 
deficiency, led to the identification of three genes that function in the 
activation of cell death: reaper (rpr), head involution defective (hid) and 
grim (Chen et al., 1996; Grether et al., 1995; White et al., 1994).  The 
proteins encoded by these genes vary considerably in size and share little 
homology amongst each other or with any other known proteins.  They do 
however contain a common 14 amino acid motif at the N-terminus, termed 
the RHG motif or the IAP-binding motif (IBM) which has been 
demonstrated to be critical for their pro-apoptotic function (Wing et al., 
2001) (Fig 1.2).  On the basis of this motif, three other pro-apoptotic 
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“reaper-like” genes have been characterized in Drosophila.  Sickle (skl) lies 
immediately adjacent to the H99 locus and like rpr, is acutely upregulated in 
response to certain apoptotic stimuli such as ionizing radiation (Christich et 
al., 2002; Srinivasula et al., 2002; Wing et al., 2002).  The thioredoxin 
peroxidase Jafrac2 is an IBM containing protein that normally resides in the 
endoplasmic reticulum of healthy cells, but is rapidly released into the 
cytosol following apoptotic stimuli (Tenev et al., 2002).  Finally, as 
previously mentioned, a Drosophila homolog of the mammalian 
mitochondrial serine protease HtrA2/Omi was recently cloned and 
characterized (Igaki et al., 2007).  DmHtrA2 is a developmentally regulated 
mitochondrial intermembrane space (IMS) protein that undergoes processive 
cleavage, in situ, to generate two distinct IBM motifs.  In response to 
apoptotic stimuli DmHtrA2 is translocated to the extramitochondrial 
compartment in a manner reminiscent of its mammalian homolog and other 
pro-apoptotic intermembrane space proteins (Challa et al., 2007).  Despite 
the virtual lack of homology between RHG proteins outside of the IBM 
motif, an abundance of data indicates that, at least in part, they function 
mechanistically in a similar fashion by disrupting the function of the same 
key regulatory molecule, Diap1.  This inhibition of Diap1 function in turn 
allows for activation of caspases and engagement of the cell death program. 
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Fig 1.2.  The RHG motif is a N-terminal region conserved among the H99 
genes (above the dashed line) and to a lesser extent in several mammalian 
proteins.  The tetrapeptides highlighted in yellow (IBM) are sufficient for 
binding to Xiap.  The Drosophila RHG domains are located immediately 
carboxy-terminal to the initiation methionine, which is presumably removed 
by methionine amino peptidase activity in vivo. All mammalian IBM-
containing proteins that have been discovered so far undergo proteolytic 
processing to expose the IBM. 
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Interestingly, heterologous expression of RHG proteins in mammalian 
cells was found to efficiently induce apoptosis in these cells, pointing yet 
again to a mechanistic conservation between fly and mammalian cell death 
pathways and suggesting the existence of mammalian RHG protein 
homologues (Claveria et al., 1998; Haining et al., 1999; McCarthy and Dixit, 
1998).  Though no mammalian counterparts with extensive sequence 
similarity to any of the Drosophila RHG proteins have been found, three 
mammalian proteins have been identified that do contain an N-terminal 
RHG tetrapeptide motif and appear to function in part via a molecular 
mechanism similar to that of the RHG proteins.  Two of these proteins, 
Smac/Diablo and HtrA2/Omi, are among the mitochondrial IMS proteins 
released into the cytosol in response to apoptotic stimuli whereas the third, 
GSPT1/eRF3, is a proteolytically processed isoform of an endoplasmic 
reticulum-associated protein whose normal role is to act during translation as 
a polypeptide chain release factor (Du et al., 2000; Hegde et al., 2003; 
Suzuki et al., 2001a; Verhagen et al., 2000).  In addition, recent screens have 
identified several other putative molecules that interact with IAPs via N-
terminal IAP binding motifs (Verhagen et al., 2007).  The validity of these 
mammalian IBM containing proteins as bona-fide regulators of apoptosis, 
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however, remains controversial and the search for legitimate RHG homologs 
is ongoing. 
 
Inhibitor of Apoptosis Proteins (IAPs) 
Diap1 belongs to the highly conserved class of cell death suppressors 
known as the Inhibitor of Apoptosis Proteins (IAPs).  Discovery of this 
protein family came from virologists originally studying a mutant form of 
the baculovirus Autographa californica nuclear polyhedrosis virus 
(AcMNPV) that resulted in premature cell death during infection of 
Spodoptera frugiperda (SF-21) insect cells.  Characterization of this 
spontaneous viral mutant determined that the baculoviral protein p35 was 
responsible for blocking the apoptotic response in the infected host cell 
(Clem et al., 1991; Friesen and Miller, 1987).  With no homology to proteins 
outside of Baculoviridae, p35 was subsequently shown to be a broad caspase 
inhibitor in several species and was quickly adopted as an invaluable tool for 
apoptosis research (Bump et al., 1995; Xue and Robert Horvitz, 1995).  The 
only other caspase inhibitor known at the time, cytokine response modifier 
A (CrmA), was also discovered by virologists, before caspases were termed 
'caspases', and before caspases were known to be the key executioners of the 
cell death program (Pickup et al., 1986).  Originally identified on the basis 
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of its ability to produce hemorrhage in developing chick embryos, CrmA 
was determined to efficiently block inflammatory responses by specifically 
inhibiting Interleukin-lβ Converting Enzyme (ICE), now known as Caspase-
1 (Palumbo et al., 1989; Ray et al., 1992).  Unlike p35, CrmA contained 
extensive homology to other proteins that immediately placed it into the 
large and ancient serpin family of serine protease inhibitors. Although they 
have no structural similarity, CrmA and p35 both inactivate their cognate 
proteases in a mechanism-based manner by behaving as ‘suicide substrates’.  
The reactive-site loop of the inhibitor binds to the active site of the caspase 
and is cleaved, inducing a conformational change that irreversibly locks the 
protease in an inactive conformation (Simonovic et al., 2000; Xu et al., 
2001).  It is believed that baculoviruses express these inhibitors to suppress 
and escape an apoptotic host response that would otherwise limit viral 
replication (Clem and Miller, 1994). 
To identify additional genes involved in the inhibition of virally 
induced apoptosis, Miller et al. conducted a screen for genes that could 
functionally complement for loss of p35.  This approach successfully 
identified such a gene from another baculovirus, Cydia pomonella granulosis 
virus (CpGV) that could also block actinomycin D induced apoptosis in SF-
21 cells.  Named inhibitor of apoptosis or Cp-iap, this gene remarkably 
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turned out to encode a protein with zinc finger motifs (the BIR domains) 
homologous to those found in several human proto-oncogenes and insect 
embryonic development genes (Crook et al., 1993).  Orthologous proteins 
that also function as cell death inhibitors have subsequently been identified 
in a wide variety of organisms including insects, mammals and plants 
making Cp-iap the founding member of an evolutionarily conserved IAP 
family of apoptosis inhibitors (Salvesen and Duckett, 2002) (Fig 1.3). 
All IAPs are characterized by the presence of between one and three 
tandem BIR domains, each approximately 70 amino acids in length and 
comprising a zinc-binding fold (Deveraux and Reed, 1999).  The BIR 
domains of IAPs are critical for their anti-apoptotic properties and in flies 
and mammals, endogenous IAPs can inhibit active caspases by direct 
binding of their BIR domains to caspase catalytic sites, by promoting the 
degradation of active caspases or by sequestering caspases away from target 
substrates (Hinds et al., 1999; Riedl et al., 2001; Tenev et al., 2005).  IAPs 
exhibit specificity towards a subset of caspases.  Mammalian Xiap, Ciap1 
and Ciap2, for example, can bind and through diverse mechanisms inhibit 
Caspase-3, -7 and -9 but do not interact with Caspase-1, -6, -8 or -10 
(Deveraux et al., 1997; Roy et al., 1997).  Moreover, the individual BIR 
domains of those IAPS with multiple BIR domains, fold into functionally 
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independent structures that target and inhibit distinct caspases.  Xiap, which 
contains three BIR domains, requires the BIR2 domain and a small N-
terminal extension of BIR2 for the inhibition of Caspase-3 and -7, whereas 
the BIR3 domain of Xiap is essential for the inactivation of Caspase-9 (Chai 
et al., 2001; Riedl et al., 2001; Shiozaki et al., 2003).  Similarly in 
Drosophila, the BIR1 domain of Diap1 was found to specifically bind the 
effector caspases Dcp-1 and Drice, while BIR2 was found to be essential for 
binding the initiator caspase Dronc (Meier et al., 2000b; Zachariou et al., 
2003). 
Not all BIR containing proteins are IAPs however, as some of these 
proteins appear not to function as bona fide inhibitors of apoptosis, but 
rather seem to have roles in other vital cellular processes.  C. elegans 
encodes two proteins, CeBir1 and CeBir2 that possess BIR domains, but 
neither are considered veritable IAPs because they have not been found to 
play a role in regulating apoptosis.  Instead, CeBir1, it’s yeast homolog 
Bir1p and its mammalian homolog Survivin, are primarily involved in 
cytokinesis as members of the chromosomal passenger complex (Fraser et 
al., 1999; Lens et al., 2006; Li et al., 1998; Rajagopalan and 
Balasubramanian, 2002; Speliotes et al., 2000). 
 
 33 
 
 
Fig 1.3.  Domain architecture of Drosophila and human IAPs.  The 
drosophila genome encodes four IAP genes; the human genome eight.  Cp-
Iap, the first IAP discovered, is also shown.  Current evidence indicates that 
only Diap1 and Xiap1 are direct inhibitors of caspase activity.  In addition to 
at least one baculoviral IAP repeat (BIR) domain, most IAPs have other 
distinct functional domains.  RING, Really Interesting New Gene; UBC, 
Ubiquitin-conjugation; NACHT, nucleotide-oligomerization domain.  
Numbers to the left indicate the length in amino acid residues. 
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Ring Domains and Ubiquitination 
In addition to BIR domains, IAPs with clearly defined roles in 
apoptosis also contain a second highly conserved zinc-binding motif at their 
carboxyl terminus called the RING domain (for Really Interesting New 
Gene.)  The RING domain can behave as an E3 ubiquitin ligase and 
functions to recruit E2 ubiquitin-conjugating enzymes to target proteins, 
which are subsequently ubiquitylated by the transfer of a 76-amino-acid 
ubiquitin peptide (Joazeiro and Weissman, 2000).  In contrast to the 
multisubunit RING E3 ligases, IAP E3 ligases combine a substrate-binding 
domain (the BIRs) and a RING domain within the same protein.  Since 
ubiquitylation of proteins has emerged as a fundamental regulatory 
mechanism in eukaryotic cells, it follows that ubiquitin-mediated protein 
regulation is involved in IAP function.   
The importance of the RING domain for the regulation of caspases 
and apoptosis in vivo was revealed by Drosophila screens that identified 
disruptive point mutations in the diap1 RING that are embryonic lethal (Lisi 
et al., 2000; Moore et al., 1998).  Contrary to much early in vitro and 
overexpression data, in vivo, Diap1 requires not only its BIR2 domain to 
bind the initiator caspase Dronc, but also a structurally intact RING domain 
to neutralize it (Chai et al., 2003; Wilson et al., 2002).  The complexity of 
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Diap1 mediated apoptosis control and the critical role of the RING in this 
task are further underscored by evidence demonstrating that Diap1 promotes 
the ubiquitylation of a number of proteins including Rpr, Hid, Grim, 
dTRAF1 and of itself by way of an autoubiquitination reaction (Kuranaga et 
al., 2002; Olson et al., 2003; Ryoo et al., 2002).  Similarly, Xiap has been 
demonstrated to ubiquitinate several proteins in a RING dependent manner 
including Smac/Diablo, Caspase-3, Caspase-9, MURR1 (a factor recently 
implicated in copper homeostasis), AIF and itself via autoubiquitination 
(MacFarlane et al., 2002; Morizane et al., 2005; Suzuki et al., 2001b; 
Wilkinson et al., 2007; Yang et al., 2000).  Genetic evidence implicating the 
Xiap RING domain in apoptosis regulation has recently been furnished by 
Schile et al., who generated a knock-in mouse expressing a RING-deleted 
Xiap.  Mouse embryonic fibroblasts (MEFs) derived from this mouse are 
strongly sensitized to TNF-α induced apoptosis.  Furthermore, deletion of 
the RING in Xiap lessens the incidence of leukemia and prolongs the 
survival of mice on a Eu-myc lymphoma background.  The authors 
demonstrated using irradiated MEFs that deletion of the Xiap RING domain 
results in reduced caspase ubiquitination and concluded that the 
ubiquitinating activity of Xiap is important for its role as a negative 
regulator of apoptosis (Schile et al., 2008). 
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The functional significance of IAP RING-mediated ubiquitylation of 
target proteins is often unclear however.  In general, a target protein can be 
subjected to several possible ubiquitylation outcomes such as 
monoubiquitylation, multi-monoubiquitylation, polyubiquitylation through a 
K48 linkage or polyubiquitylation through a non-K48 linkage.  Only 
substrates that are polyubiquitylated by a K48-linked chain of four or more 
ubiquitins are rapidly recruited to the 26S proteasome and degraded (Vaux 
and Silke, 2005).  Therefore, even though an important role of the ubiquitin 
system is to regulate the half-life of proteins by targeting them for 
degradation by the 26S proteasome, there are many ubiquitin modifications 
that do not result in protein degradation but instead alter the activity of the 
modified protein.  A prime example is provided by the regulation of Dronc 
by Diap1 in Drosophila.  Despite a requirement of the Diap1 RING finger 
for Dronc ubiquitylation and the suppression of apoptosis, Diap1 does not 
target Dronc for degradation, indicating an inhibitory, but non-degradative, 
polyubiquitylation event (Wilson et al., 2002).  Similar observations in a 
mammalian system suggest a regulatory mechanism involving IAP-mediated 
non-degradative mono-ubiquitylation of Caspases-3 and -7 (Huang et al., 
2000).  The ubiquitylation of caspases in this manner could, for example, 
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suppress them by blocking their recruitment into apoptosome complexes or 
modifying their subcellular localization. 
Given that ubiquitylation might arguably demonstrate as diverse a 
regulatory repertoire as phosphorylation, the regulation of caspases and 
other proteins by RING containing IAPs could prove enormously complex.  
It has been hypothesized that RING-mediated autoubiquitination of IAPs 
leads to their degradation and that this process is a key regulatory event in 
the apoptotic program, perhaps illustrating a paradigm in which levels of 
IAPs are carefully governed (Ryoo et al., 2002; Yang et al., 2000).  Some 
recent data suggests however that this may be an oversimplification.  In 
some contexts, RING-mediated cross ubiquitination by paralogous IAPs 
may be required to elicit degradational targeting to the proteasome.  Silke et 
al. have shown, for example, that mammalian Ciap1 binds directly to Xiap 
via a homotypic RING-RING interaction, leading to the ubiquitination and 
subsequent proteasomal degradation of Xiap (Silke et al., 2005).  It has also 
been demonstrated that Ciap2 is a direct target of Ciap1-mediated RING-
dependent ubiquitination and degradation (Conze et al., 2005).  Similarly, 
Herman-Bachinsky et al. have recently provided evidence that the RING-
finger-mediated autoubiquitinating activity of Diap1 does not involve 
formation of the Lys48-based polyubiquitin chains necessary for targeting to 
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the proteasome, but rather produces chains linked via Lys63 that serve only 
to attenuate the ligase activity of Diap1 towards its exogenous substrates.  
They argue therefore, that it is Diap2 that ubiquitinates Diap1 with the 
Lys48-based polyubiquitin tag required for proteasomal degradation 
(Herman-Bachinsky et al., 2007).  Despite these interesting observations 
however, this scenario seems improbable given that Diap2 null mutant flies, 
recently generated by two independent groups, exhibit essentially no 
apoptotic phenotype (Huh et al., 2007; Leulier et al., 2006). 
It is clear that the RING is an important regulatory domain for IAP 
stability but the precise mechanisms and role of this regulation remain 
elusive at present.  Some authors have questioned the importance of IAP 
degradation for apoptosis regulation all together, pointing out that IAP-
antagonist can inhibit IAPs and promote caspase activation irrespective of 
whether or not IAPs are degraded (Ditzel and Meier, 2002).  These authors 
suggest that Diap1 degradation is not a decisive event in the initiation of 
apoptosis, but rather a method to destroy low levels of unscheduled IBM 
protein production in healthy non-apoptotic cells.  Further study of IAPs and 
their interacting proteins is required to clarify the role of RING domains in 
apoptosis regulation. 
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Mechanisms of IAP Mediated Caspase Inhibition 
Of the eight known human BIR containing proteins, current data 
indicates that Xiap may actually be the only bona fide caspase inhibitor.  
Xiap is a 497-amino acid polypeptide with a predicted mass of 57 kD that is 
ubiquitously expressed in human tissues.  It has been the most intensely 
studied IAP and is also the most potent inhibitor of cell death in vitro 
(Duckett et al., 1996; Holcik et al., 2001; Listen et al., 1996).  Given the 
high sequence and domain conservation amongst IAPs, it had been assumed 
that they all neutralize active caspases through the same BIR-dependent 
mechanism.  Though there are indeed conserved aspects of this mechanism, 
recent biochemical and structural studies have precisely mapped the 
elements of Xiap required for caspase inhibition and surprisingly some of 
these elements are not conserved among IAPs.  This has precluded a 
universal mechanism of inhibition by this protein family and it is now 
appreciated that IAPs can inhibit caspases and apoptosis through a variety of 
distinct mechanisms (Tenev et al., 2005). 
Employing a unique strategy, which differs from that described 
previously for viral caspase inhibitors, both the BIR2 and BIR3 domains of 
Xiap use a two-site binding mechanism for potent inhibition of their 
respective caspases.  One binding site is a conserved surface groove 
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characteristic of many BIR domains that has a preference for binding the 
extreme N terminus of short peptides of defined sequence. The peptide 
sequence preferred by BIR domains, AXPX where X represents a 
hydrophobic amino acid, is termed the IAP-binding motif (IBM) (Shi, 
2002).  Activation of Caspase-3, Caspase-7 and Caspase-9 involves 
proteolytic processing that generates such an IBM in the small-subunit 
amino terminus of the caspase and crystal structures have confirmed that 
Xiap BIR domains bind to this IBM via its conserved IBM-interacting 
surface groove.  This conserved interaction surface of Xiap, referred to as an 
exosite-anchoring motif is not sufficient for potent caspase inhibition 
however.  A second non-conserved interaction between Xiap and caspases is 
required.  For inhibition of effector Caspases-3 and 7 by BIR2, residues 
directly preceding the BIR2 domain provide such an interaction.  This 
peptide loop stretches across the catalytic-binding cleft of the caspase in a 
reverse orientation relative to that of a substrate protein thereby generating a 
steric blockade prohibitive of substrate binding (Chai et al., 2001; Huang et 
al., 2001; Riedl et al., 2001).  This unusual reverse-binding mechanism had 
previously been described for members of the papain family of proteases 
which use their own amino terminal prosegment to inhibit their enzyme 
activity (Coulombe et al., 1996).  In the case of Caspase-9, rather than 
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targeting the enzyme active site directly, the BIR3 domain of Xiap abolishes 
activity using a fundamentally different mechanism.  Structural analysis of a 
BIR3/Caspase-9 complex has revealed that a helix found immediately after 
the BIR3 domain packs against the dimer interface of Caspase-9, 
sequestering Caspase-9 in a monomeric state and forcing the protease into a 
dormant conformation with a collapsed active site (Shiozaki et al., 2003).  
Xiap is the first example of a natural protease inhibitor that uses this kind of 
allosteric mechanism (Eckelman et al., 2006). 
 The closest paralogues of Xiap, Ciap1 and Ciap2, also contain three 
BIR domains and a RING domain and similar to Xiap, Ciap overexpression 
protects cells from apoptosis (Listen et al., 1996; Uren et al., 1996).  Ciap1 
and Ciap2 also contain a CARD domain and were originally identified 
through their ability to interact directly with the TNF receptor-associated 
factor TRAF2 (Rothe et al., 1995).  The BIR domains of Ciaps contain IBM-
interacting grooves that are highly conserved with those in Xiap and Ciaps 
can bind caspases in vitro.  However critical residues surrounding the BIR 
domains as revealed by the crystal structures of Xiap are not conserved in 
Ciaps and as a consequence they are incapable of directly inhibiting the 
enzymatic activity of caspases (Eckelman and Salvesen, 2006).  On the basis 
of these structural arguments, it is probable that the other human BIR-
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containing proteins, ML-Iap, Ilp2, Naip, Survivin and Bruce are not direct 
caspase inhibitors either.  In several instances this has been demonstrated.  
Vucic and colleagues showed that ML-Iap is not a tight inhibitor of Caspase-
9, Shin and colleagues have shown that Ilp2 cannot inhibit Caspase 9 in a 
physiological way on its own and Survivin is now thought to primarily be a 
regulator of the mitotic spindle (Lens et al., 2006; Shin et al., 2005; Vucic et 
al., 2005).  Earlier studies concluding that IAPs other than Xiap were direct 
caspase inhibitors have largely been revised in light of problematic 
experimental techniques, principally concerning the use of GST tags.   
The mechanisms by which Ciaps and other mammalian IAPs 
attenuate apoptosis possibly include: binding to IAP antagonists to reduce 
the amount available to antagonize Xiap, influencing signaling by NF-κB 
and MAP kinases, or targeting caspases for ubiquitylation and proteasomal 
degradation (Tenev et al., 2005).  For example, through TRAF2 interactions, 
Ciaps are recruited to TNFR1 and TNFR2 associated complexes where they 
regulate receptor-mediated apoptosis via modulation of NF-κB activity and 
suppression of Caspase-8 activation (Micheau and Tschopp, 2003a; Shu et 
al., 1996; Wang et al., 1998).  This interaction is conferred by the first two 
alpha-helices in the BIR1 domain of Ciap1 and Ciap2 (Samuel et al., 2006).  
Engagement of TNFR2 by TNF-α results in TRAF2 ubiquitination in a 
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manner that depends on the RING domain of Ciap1 (Li et al., 2002).  Ciap1 
and Ciap2 also promote proteasomal degradation of  NF-κB inducing kinase 
(NIK), a highly labile ser/thr kinase that is a critical regulator of the 
noncanonical NF-κB pathway (Varfolomeev et al., 2007).  Similarly, Xiap 
has been demonstrated to induce NF-κB and MAP kinase activation in a 
BIR1 dependent manner during TGF-ß and BMP receptor signaling through 
engagement of the NF-κB regulator TAB1 (Lu et al., 2007).  Xiap has also 
recently been shown to directly bind copper and to be involved in copper 
homeostasis (Mufti et al., 2006).  It is clear from these and other studies that 
IAPs are complex molecules with the capability to impinge on cell survival 
at multiple points in various signaling pathways. 
 Since knockout studies of mammalian IAPs (Xiap,Ciap1 and Ciap2) 
have failed to reveal significant apoptosis phenotypes, possibly due to 
redundancy or compensatory mechanisms, the strongest in vivo evidence for 
a direct role of IAPs in the regulation of caspases and apoptosis comes from 
genetic studies in the fruit fly (Conte et al., 2006; Conze et al., 2005; Harlin 
et al., 2001).  Drosophila contains four IAPs of which Diap1 appears to be 
the most critical.  Genetic loss of diap1 leads to uncontrolled caspase 
activation, resulting in premature and widespread unscheduled apoptosis 
which culminates in embryonic lethality (Goyal et al., 2000; Wang et al., 
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1999).  This suggests that diap1 provides an essential requirement for the 
inhibition of apoptosis and is consistent with the fact that diap1 has been 
shown to directly interact with at least three Drosophila caspases, the apical 
caspase Dronc and the effector caspases Drice and Dcp-1 (Meier et al., 
2000b; Zachariou et al., 2003). 
In contrast to Xiap, structural data for Diap1, which contains only two 
BIRs and a RING, is limited to complexes containing the BIR1 domain 
bound to a ten-residue peptide derived from the N terminus of Rpr or Grim, 
and the BIR2 domain alone or bound to a ten-residue peptide derived from 
the N-terminus of Hid or Grim.  In addition, the BIR2 domain of Diap1 has 
been crystallized with residues 114-123 of the initiator caspase Dronc.  
These structures reveal that the Diap1 BIR motifs contain the same 
conserved IBM-interacting surface groove found in Xiap and that this pocket 
is the site for mutually exclusive contact between caspases and the RHG 
proteins.  In a manner reminiscent of Xiap, Diap1 requires non-conserved 
residues adjacent to its BIR1 domain to efficiently bind caspases.  
Biochemical data indicate that the BIR1 domain and the adjacent carboxy-
terminal linker region of Diap1 are necessary and sufficient for direct 
inhibition of the effector caspases Drice and Dcp-1 (Tenev et al., 2005; Yan 
et al., 2004).  Due to a lack of structural information for Diap1 complexes, 
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the precise molecular mechanism of this inhibition remains unknown.  It 
may be that Xiap and processed Diap1 use a similar two-site binding 
strategy for potent inhibition of effector caspases, both using a BIR domain 
as a platform to correctly deploy an adjacent inhibitory peptide. 
The mechanism for inhibition of the initiator caspase Dronc by Diap1, 
however, is completely distinct from that of Xiap mediated caspase-9 
inhibition.  First, Diap1 binds Dronc not via an N-terminal IBM motif, but 
through a 12 amino acid fragment between the CARD and the protease 
domain of Dronc (Chai et al., 2003).  Consequently, Diap1 is uniquely able 
to bind both active Dronc and the unprocessed Dronc zymogen.  Secondly, 
Diap1 does not directly inhibit Dronc activity, but rather regulates the 
activity of Dronc through a mechanism that is dependent on its RING finger.  
Strong in vivo evidence has demonstrated that the E3 ubiquitin ligase 
activity of Diap1 is required for Dronc ubiquitination and is indispensable 
for Dronc inhibition and apoptosis regulation (Wilson et al., 2002). 
The activity of Diap1 itself may be regulated in several ways not yet 
observed for mammalian IAPs.  Diap1 contains an N-terminal fragment that 
some authors believe is autoinhibitory and must first be cleaved before 
Diap1 can interact with and inhibit effector caspases.  According to this 
model, cleavage of the N-terminus not only renders Diap1 competent for 
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caspase binding, but it also converts Diap1 into a highly unstable, Asn-
bearing N-degron of the N-end rule degradation pathway that is rapidly 
degraded (Ditzel et al., 2003).   
 Far less is known about the other Drosophila IAPs, Diap2, dBruce 
and Deterin and evidence implicating these genes in apoptosis is largely 
limited to overexpression studies (Hay et al., 1995; Jones et al., 2000; 
Vernooy et al., 2002).  Dbruce is the Drosophila ortholog of the mouse 
bruce and human apollon genes and is predicted to encode an enormous 
protein of 4852 amino acids with an N-terminal BIR domain and a C-
terminal ubiquitin conjugation (UBC) domain.  Some in vivo data supporting 
a role for dBruce as an apoptotic regulator has come from genetic screens 
designed to identify components of the rpr and hid apoptotic pathways.  
These screens isolated 11 loss-of-function alleles of dbruce that enhance 
rpr- and grim- but not hid-induced cell death and one gain-of-function allele 
that suppresses hid- but not rpr- or grim-induced death (Agapite, 2002).  
This differential pattern of enhancement and suppression is highly 
reminiscent of that observed for Diap1 mutants, raising the intriguing 
possibility that perhaps Dbruce and Diap1 function together in an E2/E3 
complex to ubiquitinate target proteins.  Unlike Diap1 however, dBruce null 
mutants are male sterile but viable, indicating that dBbruce has a more 
 47 
restricted role than Diap1 during development.  Intriguingly, dBruce has 
recently been shown to bind Klh10, a component of the testis-specific 
Cullin-3-Roc1b-dependent ubiquitin ligase complex that is required for 
caspase activation in spermatids (Arama et al., 2007).  This interaction led 
the authors to speculate that dBruce may be the IAP that spatially and 
temporally restricts caspase activation during sperm differentiation and that 
the Cullin-3 enzyme complex activates caspases by degrading dBruce in 
response to developmental cues. 
 The physiological function of Diap2 has been investigated recently by 
two groups that generated diap2 null alleles (Huh et al., 2007; Leulier et al., 
2006).  Diap2 mutant animals develop normally, are fully viable and show 
no defects in developmental or stress-induced apoptosis, suggesting that 
diap2 is dispensable for cell survival.  Instead, diap2 was found to be 
essential for the innate immune response to Gram-negative bacterial 
infection.  Drosophila melanogaster lacks an adaptive immune system and 
relies exclusively on innate immune reactions for its defense against 
microbial infection.  The immune deficiency (Imd) signaling pathway is 
activated in response to gram-negative bacteria and triggers nuclear 
translocation of the NF-κB like transcription factor Relish, which in turn 
induces expression of antibacterial genes (Hoffmann, 2003). Loss of Diap2 
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results in a profound defect in Relish nuclear translocation and antimicrobial 
peptide (AMP) expression, rendering mutant flies acutely sensitive to 
infection by gram-negative bacteria.  These results suggest that Diap2, like 
the Ciaps in mammals, may function as an E3 ubiquitin ligase in a receptor 
signaling cascade rather than as an inhibitor of caspase activation. 
 
The MAPK Pathway and Apoptosis 
 Cell survival is regulated by a multitude of extracellular and 
intracellular signals and in most tissues, suppression of apoptosis is 
dependent upon a constant supply of exogenous survival signals.  These 
signals are furnished by neighboring cells and the extracellular matrix as 
either immobilized or soluble peptide factors (Raff, 1992).  Growth factors 
such as fibroblast growth factor (FGF) and epidermal growth factor (EGF) 
are classic examples of survival factors that inactivate the intrinsic cell death 
program, thereby promoting cell survival.  These growth factors bind to and 
activate receptor tyrosine kinases (RTKs), such as the EGF receptor 
(EGFR), at the cell surface and initiate a survival signal that is propagated 
throughout the cell via a number of effector pathways (Downward, 1998) 
(Fig 1.4).  The mitogen-activated protein kinase (MAPK) cascade is one 
such effector pathway that responds to extracellular cues and transduces 
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signals from the cell surface to the nucleus via a protein phosphorelay 
system consisting of three sequentially activated kinases.  This succession of 
kinases provides a signaling framework that is amenable to feedback 
regulation and signal amplification (Fig. 1.4). 
 MAPK signaling cascades are known to modulate a number of critical 
cellular activities including gene expression, mitosis, proliferation, motility, 
metabolism and programmed cell death (Johnson and Lapadat, 2002).  
Among the three subfamilies of MAPK modules  that have been well 
characterized in multicellular organisms, it is the extracellular signal-
regulated kinase (ERK) branch which has been implicated in promoting cell 
survival (Wada and Penninger, 2004).  The canonical ERK-MAPK module 
consists of three successive serine/threonine kinases; Raf, MEK and ERK.  
Once activated, Raf initiates a phosphorylation cascade, whereby Raf 
phosphorylates and activates MEK, and MEK in turn phosphorylates and 
activates ERK.  Activated ERKs then phosphorylate and regulate the 
activities more than 160 proteins, the majority of which are nuclear proteins, 
including several transcription factors such as c-Myc, Elk-1 and Ets-2 (Yoon 
and Seger, 2006).  A central regulator of this signal transduction relay is the 
small GTPase Ras, which acts as a molecular switch in response to RTK 
activity to directly control the activity of Raf and therefore the MAPK  
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Fig 1.4.  The RTK/Ras/MAPK signaling pathway.  This illustration of the 
canonical MAPK signaling pathway highlights regulatory components that 
are conserved between humans and flies.  Conserved RTK subfamilies that 
are known to employ canonical MAPK signaling include the Egfr, Fgfr, 
Pdgfr, Insr, Vegfr, Alk, Eph, Ret and Tie receptor subfamilies.  Different 
receptors use various combinations of adaptor (Shc) and docking proteins 
such as Irs1 (Dme: Chico) to recruit Grb2 (Dme: Drk) and Sos to ligand 
activated receptor complexes.  Sos catalyzes nucleotide exchange on Ras-
GDP converting it to its active Ras-GTP form.  Active Ras engages several 
downstream signaling molecules including the MAPKKK, Raf (Dme: Pole 
hole, Phl) and PI3-Kinase (Dme: PI3K92E/Dp110).  Active Raf in turn 
phosphorylates and activates MEK (Dme: Dsor1), which phosphorylates and 
activates ERK (Dme: Rolled, rl).  KSR and 14-3-3 (Dme: leonardo) are 
scaffolding proteins that facilitate Ras-dependent ERK cascade activation at 
the plasma membrane.  Once active, ERK phosphorylates a large number of 
substrates including Ribosomal Protein S6 Kinase (RSK) in the cytosol and 
a number of transcription factors in the nucleus, including the activator Ets1 
(Dme: Pointed, Pnt) and the repressor Tel1 (Dme: Yan).  GTPase-activating 
proteins (GAPs) such as RasA3 (Dme: Gap1) and Nf1 terminate Ras 
signaling by accelerating the conversion of Ras-GTP to its inactive Ras-
GDP form.  Active Ras is also antagonized by Sprouty (Spry) proteins and 
active ERK is inactivated by the Ser/Thr phosphatase PP2A (Dme: 
Microtubule Star, Mts).  PTP, protein tyrosine phosphatase.  Dme above 
refers to the drosophila homolog if the component name is different than its 
mammalian counterpart. 
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module.  Recently, a number of ERK scaffolding proteins and signaling 
modulators have also been identified that play critical roles in determining 
the strength, duration and location of MAPK signaling (Fig 1.4). Together, 
these factors contribute to the diversity of biological responses generated by 
the RTK/MAPK signaling axis (McKay and Morrison, 2007). 
 Given the critical involvement of the ERK-MAPK module in 
transmitting cell proliferation and anti-apoptotic signals, the overwhelming 
frequency in which this pathway is aberrantly activated in human cancer is 
perhaps not too surprising.  Studies using genetic or pharmacologic 
approaches have shown that the ERK-MAPK signaling cascade is required 
for the transforming activities of Ras, the most frequently mutated oncogene 
in human cancers, as well as for tumorigenesis associated with mutationally 
activated and/or overexpressed EGFR.  Moreover, mutationally activated 
Raf has been identified in a considerable fraction and variety of human 
tumours (Davies et al., 2002).  These observations suggest a critical role for 
MAPK activation in oncogenesis, making it an appealing pathway for drug 
development.  This has stimulated intensive efforts by the research 
community and pharmaceutical industry to develop inhibitors of ERK-
MAPK signaling for cancer treatment (McCubrey et al., 2007).  
 53 
 The MAPK signalling pathways are now understood in great detail at 
the molecular level as a result of two decades of intense study employing 
genetics, molecular and cellular biology, and encompassing organisms from 
yeast to man (Fig 1.4).  Indeed, the Drosophila EGFR/MAPK pathway 
provides one of the best-characterised examples of a signaling cascade 
currently known.  The high degree of homology between components of the 
Drosophila and mammalian MAPK signaling pathways has permitted many 
unique insights derived from examination of this pathway in Drosophila to 
be extrapolated to vertebrate systems.  For example, the Sprouty (Spry) 
family of proteins is a highly conserved group of negative feedback loop 
modulators of MAPK activation that was originally discovered in 
Drosophila.  Four mammalian orthologs of Spry have subesequently been 
identified (Hanafusa et al., 2002). 
 As in mammalian systems, the Drosophila ERK-MAPK module 
mediates a plethora of cellular functions during development, including 
proliferation, survival, cell fate choice and differentiation.  Though 
activation of ERK-MAPK is has long been known to protect cells from 
apoptosis by suppressing the intrinsic cell death program, the molecular 
mechanisms  by which this occurs remain poorly understood.  New insights 
into understanding the regulation of apoptosis by survival signaling 
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pathways, however, has recently come from several genetic screens 
conducted in Drosophila, two of which are described in the next chapter.  
These studies revealed that activation of MAPK signaling inhibits the 
proapoptotic activity of the cell death inducer, hid, both by direct 
phosphorylation of the Hid protein and by downregulation of hid mRNA 
expression.  This defines a novel mechanism by which MAPK signaling 
inactivates a critical component of the apoptotic machinery (Bergmann et 
al., 1998; Kurada and White, 1998). 
 It is now exceedingly clear that apoptosis and its regulation are highly 
relevant to many human diseases.  Genetic lesions leading to diminished 
apoptosis play a general role in tumorigenesis and many cancer therapies 
result in elevated levels of cancer cell apoptosis (Ziegler and Kung, 2008).  
Over the course of the last two decades, many apoptosis effector 
mechanisms have been extensively characterized, allowing for the 
construction of elegant molecular models to explain the regulation of 
apoptosis (Fig 1.5).  Nevertheless, our understanding of the pathways that 
signal and control developmental cell death is far from complete.  Caspases 
have taken a leading role as key regulators of apoptosis, but caspase 
activation is not synonymous with cell death.  A growing appreciation for 
the non-apoptotic roles of caspases in a number of critical cellular processes 
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such as differentiation, proliferation and cell migration is driving current 
efforts to understand how caspase activity is regulated and integrated to 
achieve these varied outcomes (Kuranaga and Miura, 2007).  How, for 
example, is the extent of caspase activation within a cell temporally and 
spatially modulated to permit such specialized feats as dendritic pruning and 
spermatid individualization without eliciting self destruction (Arama et al., 
2003; Kuo et al., 2006)?  In general, we still do not understand very well 
how a particular cell chooses between life and death during development or 
disease, but it is clear that a multitude of distinct mechanisms are used to 
tightly regulate this decision.  Examples for which some insight into the 
regulation of apoptosis has been garnered include; the transcriptional 
modulation of cell death proteins such as egl-1, activation of caspases by 
oligomeric complex formation, inhibition and degradation of caspases by 
IAPs and the ubiquitin–proteasome system, activation of caspases through 
inhibition of IAPs by RHG proteins and regulation of core cell death 
proteins by phosphorylation, microRNAs and modulation of subcellular 
localization (Domingos and Steller, 2007).  Finally, recent evidence 
indicates that apoptotic cells themselves actively communicate with their 
cellular environment to stimulate cell proliferation and tissue regeneration in 
a process known as compensatory proliferation (Ryoo et al., 2004). 
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The aim of the research presented here was to use genetic and 
biochemical approaches in Drosophila to further elucidate the molecular 
mechanisms regulating the core, evolutionarily conserved caspase-dependent 
cell death pathway.  Towards this end, we present here the partial 
characterization of a novel CARD containing serine/threonine kinase as 
putative regulator of apotosis and in addition we describe the identification 
and characterization of the first endogenous gain-of-function mutation in 
Drosophila ras1.  We demonstrate biochemically that this mutant produces a 
Ras protein with deficient GTPase activity and therefore an enhanced 
signaling capacity.  The phenotypic consequence of this in various 
developmental contexts is investigated. 
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Fig 1.5.  The “Gas and Break” model of intrinsic apoptosis control. The 
central components of the execution phase of apoptosis in worms, flies and 
mammals are members of the caspase protease family.  In C. elegans the 
adaptor Ced-4 promotes activation of the caspase Ced-3.  As in mammals, 
upstream decisions are integrated by pro- and anti-apoptotic Bcl-2 protein 
family members.  In mammals and flies, two fundamental control points 
regulate caspase activation.   The figure highlights the forward drive for 
zymogen activation by oligomerization of initiator caspases within the 
apoptosome (the Gas) and the inhibition of active caspases by IAPs (the 
Brakes).  IAPs can be derepressed to release caspase activity by species 
specific IAP antagonists such as RHG proteins in flies or intermembrane 
space mitochondrial proteins discharged into the cytosol in mammals. 
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CHAPTER 2. 
Preliminary Characterizations of the GMR-hid Suppressor Su(21-3s) 
and the Predicted Ser/Thr Kinase CG11870 
 
 
 
 
 
 
The work presented in this chapter was built upon the efforts of Julie 
Agapite, Kim McCall, Chris Hynds and Andreas Bergmann who conducted 
the genetic screen from which the Su(21-3s) mutant is originally derived.  
All other data presented here represents original work. 
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Summary 
In Drosophila melanogaster, the induction of apoptosis requires the activity 
of three closely related genes, reaper (rpr), head involution defective (hid), 
and grim.  The proteins encoded by these genes induce apoptosis in part by 
inhibiting the anti-apoptotic activity of the caspase suppressor Diap1 and 
lead to activation of an evolutionarily conserved cell death pathway.  
Ectopic expression of rpr, hid or grim in the developing Drosophila eye 
elicits apoptosis and gives rise to a reduced eye phenotype.  Genetic screens 
designed to isolate modifiers of this phenotype have been extremely 
successful at identifying genes that regulate apoptosis.  In one such screen, a 
mutant, denoted Su(21-3s), was recovered as a potent dominant suppressor 
of hid induced phenotypes. We sought to further characterize this mutant 
and to identify the affected gene.  Preliminary data pointed to the unknown 
gene CG11870, predicted to encode a protein Ser/Thr kinase which, 
interestingly, is also reported to contain a putative caspase recruitment 
domain (CARD).  Our analysis, reported here, reveals that the Su(21-3s) 
suppressor phenotype is most likely not due to a mutation in CG11870.  
Nevertheless, our partial characterization of this novel CARD containing 
kinase exposed a possible interaction with the hid cell death pathway. 
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Introduction 
 Programmed cell death is a fundamental aspect of metazoan 
development.  Regulated cell death allows an organism to tightly control cell 
numbers and tissue size, and to protect itself from rogue cells that threaten 
homeostasis (Hengartner 2000).  For example, apoptosis, a morphologically 
distinct and commonly observed form of programmed cell death, is used 
defensively by organisms to eliminate cells infected by viruses, cells 
undergoing unregulated proliferation and auto-reactive lymphocytes. 
 Many of the cellular changes associated with apoptosis are due to the 
actions of an evolutionarily conserved family of cysteinyl proteases termed 
caspases (Thornberry and Lazebnik 1998).  The critical importance of 
caspases in the execution of apoptosis was initially revealed by the discovery 
that the C. elegans cell death gene ced-3 encodes a protein similar to the 
mammalian caspase, Interleukin-1β-converting enzyme (ICE) (Yuan 1993.)   
This family of proteases has since grown to include 11 members in humans, 
10 in mice, 7 in Drosophila and 4 in C. elegans (Aravind 2001, Shaham 
1998.)  Caspases are initially synthesized as inactive (or weakly active) 
zymogens, the activation of which is tightly regulated by both positive and 
negative inputs (Danial and Korsmeyer, 2004). 
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Caspases can broadly be separated into the initiator caspase group and 
the effector caspase group on the basis of domain architecture and 
physiologic function (Lincz 1998).  Effector caspases contain a short 
prodomain, are activated by proteolytic cleavage and are thought to act 
downstream of initiator caspases to execute the cell death process by 
cleaving a large number of cellular proteins.  In contrast, initiator caspases 
contain long prodomains that harbor regulatory motifs such as the caspase 
recruitment domain (CARD), are activated by an induced-proximity 
mechanism following recruitment into oligomeric complexes and are 
thought to act further upstream by cleaving a relatively limited number of 
substrates (Degterev et al., 2003). 
The activity of caspases is negatively regulated by a second highly 
conserved class of proteins with members in all eukaryotic species, termed 
inhibitor of apoptosis proteins (IAPs) (Crook et al., 1993).  Inhibition of 
caspases by IAPs is achieved through a number of diverse mechanisms 
including direct binding of IAPs to caspase catalytic sites and by targeting 
caspases for ubiquitinylation and proteasomal degradation (Tenev et al., 
2005).  Compelling in vivo evidence substantiating a role for IAPs in 
apoptosis regulation has come from genetic studies in Drosophila which 
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revealed that loss of diap1 leads to uncontrolled caspase activation and 
widespread induction of apoptosis (Goyal et al., 2000; Wang et al., 1999). 
Genetic analysis of programmed cell death in Drosophila also led to 
the discovery of three closely linked genes, rpr, grim and hid, whose gene 
products are required for the activation of developmental cell death that 
normally occurs during embryogenesis as well as the ectopic death induced 
by x-rays or developmental abnormalities (Chen et al., 1996; Grether et al., 
1995; White et al., 1994).  Although the proteins encoded by these genes do 
not show significant homology to each other or other known proteins, they 
do share a conserved 14 amino acid stretch at their N-termini (Chen 1996.)  
This conserved sequence, termed the RHG motif, has been shown in a 
number of paradigms to induce caspase dependent apoptosis in part by 
interacting with and inhibiting Diap1 (Vucic 1998, McCarthy and Dixit 
1998, Vucic 1998). 
 To further define the mechanisms by which rpr, hid and grim activate 
caspases and induce cell death, Agapite et al. conducted a genetic screen in 
Drosophila to isolate dominant modifiers of hid and rpr induced eye 
phenotypes (Agapite, 2002).  Approximately 500,000 flies were screened 
and 167 dominant modifiers recovered.  Among these were components of 
the Ras/MAPK pathway and both gain and loss of function alleles of diap1 
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and dbruce.  One mutant, designated Su(21-3s), was recovered as a strong 
dominant suppressor of hid induced phenotypes.  Contrary to what was 
initially reported in the screen, our analysis here found Su(21-3s) flies to be 
homozygous male and female sterile.  Preliminary characterization of this 
mutant also identified a polymorphism in the previously uncharacterized 
gene CG11870, predicted to encode a putative CARD containing Ser/Thr 
kinase.  Given the known role of CARD domains in caspase regulation, we 
sought to further characterize CG11870 with the aim of identifying a novel 
regulatory element in apoptosis.  We have since determined that the 
suppressor phenotype of Su(21-3s) does not map to CG11870 but 
nevertheless present an initial characterization of this predicted kinase and 
present evidence that CG11870 may in some contexts negatively regulate 
hid induced apoptosis. 
 
Results 
Recovery of Su(21-3s) as a dominant suppressor of GMR-hid induced 
apoptosis 
 Eye-specific expression of hid or rpr under control of the GMR 
promoter induces apoptosis and results in a dosage sensitive eye ablation 
phenotype (Grether et al., 1995).  Dominant modifier screens are designed to 
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detect pathway components for which small perturbations in gene dosage 
can alter such a sensitized phenotype.  This strategy allows for the recovery 
of both loss-of-function and gain-of-function mutations and provides a facile 
method for screening a large number of genomes.  This approach has been 
successful in defining a genetic pathway for R7 cell fate determination and 
identifying several core cell death genes (Dickson et al., 1996; Hay et al., 
1995; Rebay et al., 2000; Simon et al., 1991). 
The Su(21-3s) mutation was originally isolated in mutagenesis screens 
conducted by Agapite et al. as described in Fig. 1.  The results are briefly 
summarized below for reference and presented in Tables 1 and 2 (Agapite, 
2002). 
Approximately 170,000 F1 progeny of ENU and EMS mutagenized 
GMR-rpr flies were screened for dominant modifiers of the rough eye 
phenotype leading to the recovery of 25 enhancers and 5 suppressors (Table 
1).  Similarly, about 300,000 F1 progeny of ENU, EMS and x-ray 
mutagenized flies were screened for suppression of the GMR-hid phenotype 
with the recovery of 128 dominant suppressors (Table 2).  In sum total, 158 
dominant modifiers were identified in these screens. 
 Modifiers were mapped by segregation, balanced and recessive 
phenotypes were assessed.  Additionally, modifiers on the 3rd chromosome  
 65 
 
 
Fig. 2.1.  Scheme for the dominant modifier screens conducted by Agapite et 
al.  (A) GMR-rpr screen.  yw; GMR-rpr81 homozygous males were fed either 
0.25mg/ml ENU or 25 mM EMS.  F1 progeny, were screened for 
suppression or enhancement of the parental rough eye phenotype.  Of the 
170,000 F1 progeny screened, ~95% derived from ENU treated males,   (B) 
GMR-hid screen.  yw males were treated as above or with 4500 rad x-rays 
and then crossed to GMR-hid10 homozygous females.  F1 progeny were 
screened for suppression of the GMR-hid10 rough eye phenotype.  Of the 
300,000 F1 progeny screened, ~49% derived from EMS treated males, 
~49% from x-ray treated males and 2% from ENU treated males. 
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Table 1. GMRrpr modifiers: Summary of genetic interactions 
Groups Map pos. 
No. of 
alleles 
Pheno-
type GMR-rpr GMR-hid 
GMR-
grim 
GMR-
rho1 
GMR-
phyl 
Star 21E4 13-2e 4 
SemLth 
Lethal 
Enh 
Enh 
ND 
ND 
ND 
ND 
ND 
ND 
ND 
ND 
GMR-
rpr81  
2 
11-1e 
7-2s 
Viable 
Rep 
Lethal 
Sup 
Enh 
Sup 
ND 
ND 
ND 
ND 
ND 
ND 
ND 
ND 
ND 
ND 
ND 
ND 
diap1 72D1 6-3s 11-3e 
Viable 
Lethal 
Sup 
Enh 
Sup 
Enh 
ND 
Enh 
ND 
-- 
-- 
-- 
dBruce 86A7 10 2-3e 
Mst  
Lethal 
Enh 
Enh 
-- 
-- 
Enh 
Enh 
-- 
-- 
-- 
-- 
Delta 92A1 10-12e Lethal Enh Enh Enh Enh Enh 
Other 
-th-st- 
sr-e 
sr-e 
5 
5-2s 
5-4e 
Viable 
Viable 
Viable 
Enh 
Sup 
Enh 
-- 
Sup 
Enh 
Enh 
ND 
Enh 
-- 
ND 
Enh 
-- 
Sup 
Lethal 
Complementation groups are named for the known gene to which they 
correspond.  The group named “other” consists of mutants that could not be 
placed into a complementation group. -th-st- indicates that the mutation was 
roughly mapped by meiotic recombination around the markers th and st and 
may be located on either side, whereas sr-e indicates that the mutation maps 
between sr and e.  Alleles with the same map position and similar 
phenotypes are grouped together for simplicity.  Single alleles are named.  
Sup, suppressor; Enh, enhancer; --, no effect; ND, not done; Mst, male 
sterile; SemLth, semi lethal. 
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Table 2. GMR-hid suppressors: Summary of genetic interactions 
Groups Map pos. Alleles 
Pheno-
type 
GMR-
rpr 
GMR-
grim 
GMR-
phyl hs-hid 
vg-// 
hid 
sprouty 63D2 
23-14s 
25-1s 
27-1s 
28-4s 
30-5s 
Lethal 
Lethal 
Lethal 
Lethal 
Lethal 
Sup 
Sup 
Sup 
Sup 
Sup 
Sup 
ND 
Sup 
Sup 
Sup 
-- 
-- 
W.su 
W.su 
W.su 
Sup 
Sup 
Sup 
Sup 
ND 
-- 
-- 
ND 
-- 
-- 
Gap1 67C10 
21-1s 
22-2s 
23-9s 
24-6s 
26-2s 
Ro, wv 
Ro, wv 
Ro, wv 
Ro, wv 
Ro, wv 
WS 
WS 
ND 
WS 
Sup 
Sup 
Sup 
ND 
Sup 
Sup 
-- 
-- 
ND 
 W.su 
-- 
Sup 
Sup 
Sup 
Sup 
Sup 
-- 
-- 
-- 
-- 
-- 
diap1 72D1 
21-2s 
21-4s 
22-8s 
23-4s 
23-8s 
33-1s 
41-8s 
45-2s 
SemLth 
Lethal 
Lethal 
Lethal 
Lethal 
Lethal 
Lethal 
SemLth 
Sup 
Enh 
Enh 
Sup 
Sup 
Enh 
Enh 
Sup 
Sup 
ND 
Enh 
Sup 
Sup 
Enh 
ND 
ND 
-- 
-- 
ND 
W.su 
-- 
W.en 
-- 
ND 
Sup 
Sup 
Sup 
Sup 
Sup 
Sup 
Sup 
ND 
Sup 
Sup 
-- 
Sup 
Sup 
Sup 
ND 
Sup 
Su(GMRhid) 
2A 2
nd 
26-3s 
32-1s 
43-4s 
Lethal 
Lethal 
Lethal 
Sup 
Sup 
ND 
ND 
ND 
ND 
ND 
ND 
ND 
ND 
ND 
ND 
ND 
ND 
ND 
Su(GMR)2A 2nd0 
22-1s 
27-2s 
29-4s 
30-2s 
Lethal 
Lethal 
Lethal 
Lethal 
Sup 
Sup 
Sup 
Sup 
ND 
ND 
ND 
ND 
WS 
WS 
-- 
 Sup 
ND 
ND 
ND 
ND 
ND 
ND 
ND 
ND 
dBruce 86A7 23-6s Lethal Enh Enh W.en Sup Sup 
glass 91A3 23-3s Ro Sup Sup Sup -- -- 
Su(GMRhid) 
3A 
sr-e 
3rd 
23-15s 
29-2s 
Lethal 
Lethal 
Sup 
Sup 
Sup 
ND 
W.su 
Sup 
Sup 
ND 
Sup 
-- 
Su(GMRhid) 
3B 
sr-e 
3rd 
-sr- 
sr-e 
-sr-e- 
-sr- 
sr-e 
3rd 
24-3s 
38-5s 
38-7s 
38-8s 
38-11s 
38-13s 
40-4s 
40-6s 
Rep, ro 
Rep, ro 
Rep, ro 
Rep, ro 
Rep, ro 
Rep, ro 
Rep, ro 
Rep, ro 
Sup 
Sup 
Sup 
ND 
Sup 
Sup 
Sup 
Sup 
ND 
ND 
ND 
ND 
ND 
ND 
ND 
ND 
WS 
ND 
Sup 
Sup 
Sup 
Sup 
ND 
Sup 
Sup 
ND 
ND 
ND 
-- 
ND 
ND 
ND 
-- 
-- 
-- 
-- 
-- 
-- 
-- 
-- 
Su(GMR)3A 3rd 
24-9s 
28-1s 
30-6s 
32-3s 
Lethal 
Lethal 
Lethal 
Lethal 
Sup 
Sup 
Sup 
Sup 
ND 
ND 
Sup 
Sup 
W.su 
W.su 
Lethal 
Sup 
-- 
-- 
ND 
ND 
ND 
-- 
ND 
ND 
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Table 2. GMR-hid suppressors: Summary of genetic interactions 
32-8s Lethal Sup Sup Sup W.su ND 
Other 
-th-st- 
th-st- 
st-cu 
-cu- 
-cu- 
cu-sr 
-sr- 
-sr- 
-sr- 
-sr- 
sr-e 
sr-e 
sr-e 
sr-e 
sr-e 
sr-e 
sr-e 
sr-e 
24-4s 
41-1s 
27-17s 
21-3s 
39-1s 
23-5s 
22-6s 
24-8s 
30-4s 
41-4s 
24-2s 
28-7s 
40-5s 
41-2s 
41-6s 
41-7s 
43-1s 
43-5s 
Viable 
Viable 
Lethal 
Viable 
Ro 
Lethal 
Wv 
Viable 
Viable 
Ro 
Rep, ro 
Rep, ro 
Lethal 
Lethal 
Ro 
Lethal 
Wv 
Rep, ro 
ND 
ND 
ND 
Sup 
Sup 
Sup 
Sup 
Sup 
ND 
ND 
Sup 
Sup 
Sup 
Sup 
Sup 
Sup 
ND 
ND 
ND 
ND 
Sup 
Sup 
ND 
Sup 
ND 
ND 
ND 
ND 
ND 
ND 
Sup 
Sup 
ND 
Sup 
ND 
ND 
ND 
ND 
ND 
-- 
-- 
W.su 
Sup 
W.su 
ND 
ND 
Sup 
Sup 
-- 
Sup 
Sup 
Sup 
ND 
ND 
Sup 
ND 
W.su 
Sup 
Sup 
W.su 
Sup 
Sup 
ND 
ND 
W.su 
Sup 
W.su 
ND 
ND 
ND 
ND 
ND 
-- 
-- 
ND 
Sup 
-- 
W.su 
-- 
-- 
-- 
-- 
-- 
-- 
Sup 
Sup 
-- 
Sup 
-- 
-- 
Legend is as for Table 1. -th-st-, -cu- and -sr- indicate that the mutation 
maps around the designated markers and may be located on either side.  st-
cu, cu-sr and sr-e indicate that the mutation maps between the designated 
markers.  The mutation characterized in this study, su(21-3s), is highlighted 
in yellow.  Rep, reduced eye pigmentation; Ro, rough eye; Wv, extra wing 
veins; W.su, weak suppressor;  W.en, weak enhancer; --, no effect; ND, not 
done; Sup, suppressor; Enh, enhancer; SemLth, semi lethal.  vg-//hid refers 
to vg-Gal4;UAS-hid. 
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were roughly mapped by meiotic recombination.  Complementation analysis 
using phenotype and map information placed 133 of the modifiers into 13 
complementation groups.  The remaining mutants represented single hits or 
had no recessive phenotype and could not be placed into a complementation 
group.  The location and phenotype of some of these, however, suggest that 
they may be viable alleles of identified lethal complementation groups. 
 To enrich for mutants that specifically affect rpr and hid induced cell 
death, rather than expression from the GMR promoter or general eye 
development, modifiers were subjected to a panel of secondary screens 
(Tables 1 and 2).  The effect of modifiers against GMR-phyl or GMR-rho 
induced eye phenotypes, which are unrelated to cell death, were assessed.  It 
was surmised that death specific mutants would not affect these phenotypes 
whereas those affecting GMR promoter expression or eye development 
would (Chang et al., 1995; Hariharan et al., 1995).  Conversely, mutants 
involving apoptosis genes were expected to modify cell death phenotypes in 
alternative contexts, while those affecting GMR promoter expression or eye 
development, whose effects should be eye specific, would not.  To this end, 
dominant suppressors from the GMR-hid screen were tested for their ability 
to suppress the lethality induced by hs-hid or the ablated wing phenotype 
resulting from vg-Gal4, UAS-hid expression.  Finally, to compare the 
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similarity of rpr, hid and grim induced cell death pathways, modifiers were 
tested against GMR-rpr, GMR-hid and GMR-grim phenotypes.  These 
secondary screens allowed for the elimination of several complementation 
groups including glass, which encodes the transcription factor that drives 
GMR expression, Su(GMR)2A and Su(GMR)3A, which are known to 
indirectly and non-specifically affect GMR promoter expression, and 
Su(GMR-hid)3A and Su(GMR-hid)3B, which have not been assigned to 
previously characterized genes (Barrett et al., 1997; Moses and Rubin, 
1991).  Also eliminated were 4 alleles linked to the parental GMR-rpr 
transgene.   The remaining mutants comprised a cell death enriched subset of 
modifiers consisting of 40 mutants that fall into 6 complementation groups, 
plus 18 single alleles. 
Of the 6 complementation groups identified in these screens, 3 
corresponded to genes that regulate EGF receptor (EGFR) signaling.  Five 
loss-of-function (lof) alleles each of gap1 and sprouty, both negative 
regulators of EGFR/MAPK signaling, were recovered as strong, hid specific 
suppressors.  These mutants have been further characterized and were used 
to demonstrate that EGFR/MAPK signaling specifically inhibits the 
proapoptotic activity of Hid by direct phosphorylation and to provide a 
mechanistic link between survival signaling and the apoptotic machinery 
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(Bergmann et al., 1998).  Five lof Star alleles were isolated as enhancers of 
GMR-rpr.  Star is required for the correct processing of Spitz, a stimulatory 
ligand of EGFR (Shilo, 2005).  Though EGFR/MAPK signaling does not 
directly impinge on Rpr activity, star lof alleles exhibit a dominant rough 
eye phenotype, perhaps in part due to a reduced suppression of endogenous 
Hid activity and consequently appear as enhancers of GMR-rpr. 
Anticipated was the recovery of mutations in diap1, a known 
regulator of hid and rpr induced cell death and accordingly, 10 diap1 alleles 
were isolated in these screens.  Mutations in diap1 included both loss-of-
function (lof) alleles that enhance rpr, hid and grim induced death and two 
classes of gain-of-function (gof) alleles that either potently suppress death 
induced by all three RHG proteins or, alternatively, potently suppress hid 
induced death but enhance rpr and grim induced death.  This latter class of 
gof mutants represents RING domain mutations in diap1 and highlights a 
significant distinction between the hid pathway and the rpr and grim 
pathways.  The diap1 mutants isolated in these screens have been pivotal in 
several structure-function analyses employed to construct our current models 
of apoptosis and are described extensively elsewhere (Goyal et al., 2000; 
Ryoo et al., 2002; Wilson et al., 2002). 
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The two remaining complementation groups originally defined 
previously uncharacterized genes and Su(GMR-hid)2A remains as such.  The 
other group, consisting of 12 alleles, was of particular interest because these 
mutants display a differential modulation of the hid, rpr and grim pathways 
in a manner reminiscent of diap1 RING mutants, enhancing GMR-rpr and 
GRM-grim phenotypes but having no effect on or suppressing those of 
GMR-hid.  These alleles were mapped using a combination of meiotic 
recombination, P-element induced male recombination and deficiency 
mapping to a 74 Kb interval on the right arm of the third chromosome.  Two 
converging chromosome walks were then conducted to identify and clone 
dbruce.  This enormous 4852 amino acid protein, containing an N-terminal 
BIR and C-terminal UBC domain, is the Drosophila ortholog of mouse 
Bruce and human Apollon (Hauser et al., 1998; Vernooy et al., 2002).  The 
unique combination of a BIR domain and a UBC domain immediately 
suggested a model in which dBruce inhibits apoptosis by ubiquitinating, via 
its UBC domain, proapoptotic BIR binding factors such as caspases, Rpr or 
Grim.  Evidence that dBruce is cytoprotective against caspases and partial 
characterization of some of the dbruce mutants isolated in these screens has 
been described (Arama et al., 2003).  Molecular lesions in 9 of the dbruce 
alleles have been identified. 
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Of the remaining 18 modifiers that could not be placed into 
complementation groups, 1 was identified as an allele of delta and 5 others 
(9-4e, 9-5e, 14-1e, 14-2e and 16-3e) possibly represent weak hypomorphs of 
diap1 as they have similar differential phenotypes and map close to the 
diap1 locus. 
 The Su(21-3s) mutant was the only remaining uncharacterized allele 
found to potently and dominantly suppress all the hid-induced phenotypes 
tested (wing/eye/organismal lethality) without affecting GMR-phyl (Table 
2).  It was also reported in the screen to dominantly suppress GMR-rpr and 
GMR-grim induced eye phenotypes.  The dominant suppressor phenotype 
associated with Su(21-3s) was roughly mapped by meiotic recombination to 
the right arm of the 3rd chromosome near the visible marker, curled.  This is 
the same general area to which dbruce was roughly mapped.  However, 
unlike dbruce homozygotes, which are male sterile, Su(21-3s) homozygotes 
were reported to be fertile with no obvious phenotype.  In addition, all 12 
dbruce alleles were found to enhance GMR-rpr and GMR-grim induced 
phenotypes and not to affect those of GMR-hid (excepting the lethal allele 
dbruce23-6s).  Since no cell death genes that could readily be mutated to 
explain the Su(21-3s) suppressor phenotypes were immediately obvious in 
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the area, the possibility that Su(21-3s) represented a mutation in a novel 
apoptotic regulatory element was considered. 
 Despite the differences in Su(21-3s) and dbruce phenotypes, it was 
also considered that Su(21-3s) might be an unusual allele of dbruce given 
their mutual proximity.  Therefore, Su(21-3s) was included in the analysis 
that led to the cloning of dbruce.  Southern blot analysis of the interval to 
which dbruce had been mapped unexpectedly revealed a polymorphism in 
Su(21-3s) relative to wildtype.  Further localization of this polymorphism by 
PCR uncovered a 2Kb insertion within a presumptive intron of the unknown 
gene CG11870.  This previously uncharacterized locus is predicted to 
encode a protein Ser/Thr kinase (Fig. 2).  Interestingly, this kinase was also 
reported to contain a putative caspase recruitment domain (CARD), which is 
found in a number of known cell death regulators.  Taken together, these 
data suggested that the phenotypes associated with Su(21-3s) might derive 
from a mutation in CG11870 and the possible presence of a CARD domain 
was sufficiently intriguing to warrant further study of this gene. 
 
Recharacterization of Su(21-3s) phenotypes 
 Since a considerable amount of time had lapsed between the original 
characterization of mutants isolated in the genetic screens conducted by  
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Fig. 2.2. Schematic diagram illustrating the predicted gene structure of 
CG11870.  For simplicity, only two of four mRNAs are depicted in blue.  
Both are supported by EST data from adult testes (AT) and third instar larva 
(LP) and both are expected to encode a protein of 1427 amino acids.  Along 
with a high probability Ser/Thr kinase domain, several other motifs are 
predicted with a lower probability, including a CARD domain within the 
kinase motif.  The red triangle indicates the location of the strider transposon 
insertion in Su(21-3s) flies and the red arrow indicates the binding site of the 
DIG-labelled probe used for northern analysis. 
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Agapite et al. and initiation of the studies reported here, we first sought to 
recharacterize in greater detail the phenotypes associated with the Su(21-3s) 
mutant.  This analysis led to a number of unanticipated findings that 
confounded somewhat are initial hypothesis concerning this mutant.  As can 
be seen from the data in Table 2, Su(21-3s) had been classified as recessive 
viable with no obvious phenotypes.  Specifically, Su(21-3s) was stated to be 
recessive fertile (Agapite, 2002).  In our follow up examination, however, it 
was discovered that Su(21-3s) in fact harbored a mutation that rendered it 
recessive male and female sterile.  Dissection of gonads from adult Su(21-
3s) flies revealed severely atrophied testes and ovaries in heterozygotes and 
an even more marked degeneration of testes from male homozygotes.  
Ovaries in homozygous Su(21-3s) females could not be isolated, presumably 
because they were too deteriorated (Fig. 3).  The reason for the discrepancy 
between our observations here and those first reported remains unclear.  It is 
possible, given the nature of mutagenesis in general and the mosaicism 
associated with chemical mutagens in particular, that a second mutation in 
the background of Su(21-3s) flies initially went undetected and over time 
was fixed in the population (Rubin, 1990).  Alternatively, a spontaneous 
mutation may have arisen at some point.  Why in either case a recessive 
sterile mutation in a mixed population would persist is another matter for 
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speculation.  Perhaps it conferred some sort of survival advantage in the 
context of other mutations located on the mutagenized chromosome.  It also 
had to be considered that slight imprecisions can occur during the execution 
of such large scale screens involving a number of different individuals.  In 
any event, no determination could immediately be made as to whether the 
sterility and suppressor phenotypes of Su(21-3s) were linked given that 
mutations with both features are known (Baum et al., 2007; Mendes et al., 
2006).  It was therefore resolved to map both phenotypes in order to clarify 
their relationship with each other and to the polymorphism identified in 
CG11870. 
 In addition to uncovering the sterility phenotype associated with 
Su(21-3s), our reanalysis of its suppressor phenotype exposed another 
discrepancy with the data originally reported in the screens.  Briefly, Su(21-
3s) was originally reported to suppress GMR-hid, GMR-rpr and GMR-grim 
induced eye phenotypes.  A careful reevaluation of these interactions 
however, clearly demonstrated that Su(21-3s) specifically suppresses only 
hid induced phenotypes and has no affect on GMR-rpr or GMR-grim.  The 
details and consequences of this finding are presented in the next chapter 
and will not be discussed further here. 
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Fig. 2.3.  The Su(21-3s) mutation results in atrophy of the testes in males (B 
and C) and the ovaries in females (E).  Ovaries could not be found in Su(21-
3s) homozygous females.  Yw testes (A) and ovaries (D) are included for 
comparison.  All images were taken at the same magnification. 
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 Despite a partial reclassification of Su(21-3s) phenotypes, the 
evidence implicating CG11870 as a gene of interest remained unchanged.   
Accordingly, while the genomic mapping of Su(21-3s) phenotypes was 
underway, we preceded with a preliminary characterization of CG11870. 
 
CG11870 is predicted to encode a protein Ser/Thr kinase 
 The Flybase annotation for CG11870 reports a gene length of 35581 
bp with a cytological map location 86A3-86A6.  Strong EST data derived 
from most tissues and stages indicate the production of four differentially 
spliced mRNAs ranging in size from 4357 bp to 5076 bp.  The shortest 
mRNA consists of 12 exons, lacks coding exon 6 and is expected to encode 
a protein of 1180 aa.  The remaining mRNAs all contain 13 exons including 
coding exon 6 and are predicted to encode a protein of 1427 aa.  Both 
protein isoforms are electronically inferred to function as receptor signaling 
Ser/Thr protein kinases in cytoskeleton organization and biogenesis.  At the 
time these studies were initiated, CG11870 was also predicted to comprise a 
putative CARD, albeit with low probability, as well as a number of other 
interesting features (Fig. 2).  Interestingly, the short protein isoform of 
CG11870 alone includes a so called TREACLE or TCS fingerprint, 
implicated in nucleolar trafficking (Wise et al., 1997).  The only proteins 
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with significant homology to CG11870 outside of the universally conserved 
kinase domain and the other recognized conserved motifs come from Aedes 
aegypti and Anopheles gambiae.  Other than these electronically inferred 
insights, CG11870 remains largely uncharacterized. 
 
Northern analysis of CG11870 mRNA 
 Su(21-3s) mutants were determined by PCR to contain an insert of 
approximately 2Kb within intron 3 of the CG11870 locus.  Subsequent 
analysis by sequencing revealed this insertion to be a 1828bp degenerate 
fragment of the Strider or Juan non-LTR retrotransposon.  To date, 9 of 
these elements have been detected in the Drosohophila genome, 6 of which 
are full length (Kaminker et al., 2002).  Non-LTR retrotransposons are 
eukaryotic mobile genetic elements that transpose by reverse transcription of 
an RNA intermediate and can be mobilized during mutagenesis experiments.  
It was unclear whether the insertion identified in Su(21-3s) would disrupt 
proper splicing or expression of CG11870 and whether this was the cause of 
the dominant suppressor phenotypes observed in this mutant.  We therefore 
performed a northern analysis of wildtype and Su(21-3s) mutant flies using a 
DIG-labeled probe directed against the last coding exon of CG11870.  A 
faint but clearly visible band of about 5kb was detected in total RNA 
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prepared from adult wildtype and mutant flies and from wildtype embryos 
(Fig 4).  Quantitation of the blot using actin mRNA as a loading control 
revealed no significant difference in expression level between wild type and 
mutant flies and no differences in transcript size were detected.  This 2Kb 
insertion does not appear to affect CG11870 expression in the adult fly and 
argued against an involvement of CG11870 in Su(21-3s) phenotypes.  
However, the possibility remains that the insertion might have tissue or 
timing specific effects on expression or result in minor splicing defects not 
detectable by northern. 
 
Overexpression of CG11870 in the fly eye suppresses GMR-hid 
 Though an attractive feature of dominant modifier screens is the 
ability to detect and therefore isolate weak hypermorphs, in general it is 
much easier to induce a loss-of-function mutation in a gene than a gain-of-
function mutation,  We presumed this to be the case for Su(21-3s) and 
assumed that, if a hypomorphic allele of CG11870 suppresses cell death, 
then a hypermorph may induce it.  To test this, we overexpressed a cDNA 
encoding the long isoform of CG11870 in the fly eye using the GMR 
promoter.  A total of 15 individual GMR-CG11870 transgenic lines were 
generated and examined.  No observable phenotypes were detected in any of  
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Fig. 2.4. Northern analysis of total RNA from adult flies with a Dig-labeled 
RNA probe made from the 3’ exon of CG11870.  The probe detects a faint 
band at the correct size of ~5 Kb confirming that CG11870 is an expressed 
gene.   Quantitation of the blot using actin mRNA as a loading control 
revealed no significant differences in expression between wildtype controls 
(yw and Sb/TM6B) and Su(21-3s).   Molecular weight markers are indicated 
on the left. 
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 the lines when either one or two copies of the transgene were present.  This 
suggests that CG11870 is not a pro-apoptotic molecule.  When these 
transgenic lines were placed in a GMR-hid background however, several 
lines over-expressing CG11870 were found to weakly suppress the GMR-hid 
induced rough eye phenotype (Fig. 5).  A similar effect was observed when 
we used GMR-Gal4 in conjunction with UAS-CG11870 to drive expression 
in the eye.  As with GMR-CG11870, GMR-Gal4/UAS-CG11870 exhibits no 
observable phenotypes on its in own, but is able to suppress the rough eye 
phenotype induced with GMR-hid (Fig. 6).  Taken together, these over-
expression studies raise the intriguing possibility that CG11870 can inhibit 
hid induced cell death.  In this case, the insertion present in Su(21-3s) flies 
would have to be a gain-of-function mutation.  This seemed unlikely given  
the Northern results and for additional reasons discussed below.  Instead,  it 
seems we may have uncovered this feature of CG11870 strictly by 
serendipity. 
 
The Su(21-3s) sterility phenotype maps to the zpg locus 
 Given that the sterility phenotype of Su(21-3s) was recessive, we 
assumed it to be loss of function and hence amenable to deficiency mapping.   
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Fig. 2.5.  Flies overexpressing the long isoform of CG11870 can suppress 
the GMR-hid induced rough eye phenotype.  The genotype of each eye is 
indicated immediately underneath.  B3, B4, B13, B38 and B53 represent 
independent GMR-CG11870 transgenes.  Transheterozygous allelic 
combinations were used to minimize transgene insertion affects. 
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To this end, we obtained 22 overlapping molecularly defined deletions from 
the Exelixis stock center covering the interval to which the Su(21-3s) 
suppressor phenotype had originally been roughly mapped in the modifier 
screens.  This region, from 84B2 to 88C1 of the right arm of the third 
chromosome, also includes the CG11870 locus as well as dbruce.  All 22 of 
these deletions complemented the sterility phenotype of Su(21-3s).  This 
strongly indicated that the sterility of Su(21-3s) flies was neither due to a 
mutation in dbruce nor related to the polymorphism identified in CG11870.  
Furthermore, these results demonstrated that the sterility phenotype of 
Su(21-3s)  did not map to this region and therefore was not linked to the 
suppressor phenotype.  This established that Su(21-3s) contained two 
separable mutations, one recessive that causes male and female sterility and 
the other a dominant suppressor of hid induced phenotypes. 
 To further localize the gene responsible for the sterility phenotype, we 
first thought to continue with the deficiency mapping.  However, while 
waiting for the arrival of a new batch of deletions, it was noticed that the 
atrophied gonads of Su(21-3s) resembled somewhat those of mutants under 
analysis in an unrelated study.  This other investigation was focused on the  
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Fig. 2.6.  Overexpression of CG11870 in the eye using the Gal4/UAS 
system also suppresses GMR-hid induced apoptosis.  Two examples are 
given for each genotype, which is indicated immediately underneath each 
pair of eyes.  E11, E19 and E69 represent independent UAS-CG11870 
transgene insertions. 
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involvement of caspases during Drosophila spermatogenesis and a collection 
of male sterile mutants with defects in spermatid individualization had been 
obtained from the Zuker stock of mutagenized flies.  The third chromosome 
collection of this publicly available stock consists of 6,000 partially 
characterized lines derived from an EMS mutagenesis (Koundakjian et al., 
2004).  Remarkably, of these 6000 mutants, only 24 are reported to be both 
male and female sterile, suggesting that relatively few genes can be mutated 
to elicit the sterility of both sexes in Drosophila.  When these 24 lines were 
crossed to Su(21-3s), five failed to complement its sterility phenotype.  A 
search of the literature fortuitously uncovered two of these Zuker mutants 
that had previously been identified as loss of function alleles of zero 
population growth (zpg) (Tazuke et al., 2002).  The zpg locus in the Su(21-
3s) mutant was subsequently sequenced and a mutation at position 662 of 
the cDNA resulting in an amino acid substitution (G221D) within a highly 
conserved region of the protein was identified.  This confirmed that the 
sterility phenotype of Su(21-3s) was due to a loss of function mutation in 
zpg and that the two Su(21-3s) phenotypes were not linked.  Zpg maps to 
65B5 on the left arm of the third chromosome and the two Su(21-3s) 
phenotypes were easily separated by meiotic recombination.  All subsequent 
analyses of the Su(21-3s) mutant, now recessive fertile as initially reported, 
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were conducted in this fresh genetic background and are discussed at length 
in the following chapter. 
 
Discussion 
 In this chapter, we describe the initial isolation and characterization of 
the Drosophila mutant Su(21-3s).  We also present preliminary molecular 
data on the predicted protein Ser/Thr kinase CG11870 and provide evidence 
showing that a mutation in this gene is unlikely to give rise to the Su(21-3s) 
mutant phenotypes as originally hypothesized. 
 The dominant hid suppressor, Su(21-3s), is the product of a genetic 
screen carried out to isolate genes that can modulate the eye ablation 
phenotypes elicited by expressing hid or rpr under the control of an eye-
specific promoter.  Roughly 500,000 flies were screened and 167 dominant 
modifiers recovered.  Secondary screens allowed us to compile a cell death 
specific subset of 58 modifiers of which 40 could be placed into six 
complementation groups that define both known and unknown genes.  This 
includes 3 genes, Star, gap and sprouty involved in EGFR/MAPK signaling, 
the known cell death regulator diap1, the enormous BIR and UBC 
containing protein dbruce and a gene, Su(GMRhid)2A, that remains to be 
identified.  Analysis of these mutants have provided several valuable 
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insights concerning the regulation of apoptosis and generated a multitude of 
tools that have proven essential in a number of studies.  For example, the 
large number of diap1 mutants obtained in this study, both gain and loss of 
function, permitted structure function assessments of Diap1 that provided 
strong in vivo evidence for mechanistic models of IAP apoptosis inhibition 
(Goyal et al., 2000; Wang et al., 1999; Zachariou et al., 2003).  Moreover, 
diap1 RING mutants derived from this screen have been used to implicate 
the ubiquitin system in apoptosis regulation and to provide evidence that 
degradation of caspases as well as Diap1 itself are key regulatory events in 
cell survival and death (Ryoo et al., 2002; Wilson et al., 2002). 
 Su(21-3s), included in the cell death specific subset of modifiers 
described above, was isolated as a strong dominant suppressor of GMR-hid.  
This mutant was reported at the time the screen was originally conducted to 
be viable with no obvious recessive phenotypes, to dominantly suppress hid 
induced organismal lethality and wing phenotypes and to map near the 
marker curled on the right arm of the third chromosome.  It was also 
reported to be a suppressor of GMR-rpr and GMR-grim.  Finally, because 
the complementation group encompassing dbruce alleles mapped to a 
similar position on the third chromosome, Su(21-3s) was included in the 
molecular analysis that led to the identification and cloning of dbruce.  
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During the course of this analysis, a 2Kb insertion within the unknown gene 
CG11870, was identified in Su(21-3s) flies.  This suggested the possibility 
that a mutation in CG11870 could be responsible for the phenotypes 
associated with Su(21-3s).  Our suspicions were bolstered by the fact that 
CG11870 was predicted to encode a protein Ser/Thr kinase with a putative 
CARD, a motif present in several known cell death regulators (Park et al., 
2007).   
 Though the features of Su(21-3s) were considered interesting enough 
to warrant further study, it was a number of years until the investigation 
reported here was initiated.  When the Su(21-3s) mutant was next examined, 
it was discovered to harbor a recessive sterility contrary to its initial 
characterization.  We first showed using deletions that this sterility 
phenotype was not related to CG11870 or dbruce and that it was separable 
from the suppressor phenotypes associated with Su(21-3s).  Subsequent 
analysis revealed that the sterility phenotype was due to a mutation in zpg, a 
germline-specific gap junction required for the survival of early 
differentiating germ cells (Tazuke et al., 2002).  Fearing this mutation might 
confound analysis of the suppressor phenotype, it was crossed out of the 
Su(21-3s) line by meiotic recombination.  This yielded a Su(21-3s) line that 
is fully fertile.  Though the detection and removal of this zpg mutation was 
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unexpected, it was not relevant to our supposition that the insertion in 
CG11870 might be responsible for suppressor phenotypes that remain 
associated with Su(21-3s).  We therefore preceded with a preliminary 
characterization of this predicted kinase. 
 Since the insertion found in CG11870 of Su(21-3s) falls within an 
intron, it could only be mutagenic by disrupting expression in some way.  
Northern analysis of CG11870 transcripts from adult flies detected a faint 
RNA band of the correct size (~5Kb), but failed to reveal any alterations in 
size or levels between wildtype and Su(21-3s).  This result argues that the 
insertion present in Su(21-3s) does not affect the transcription of CG11870 
and that it can not account for the phenotypes observed in Su(21-3s) flies.  In 
addition, the entire CG11870 ORF in wildtype and Su(21-3s) flies was 
sequenced but also revealed no differences, precluding the possibility that a 
mutation in the coding sequence of CG11870 was concomitantly induced by 
a transposition event. 
 When CG11870 was over-expressed in the fly eye, no cell death was 
observed.  Instead, overexpression of CG11870 was able to moderately 
suppress the cell death induced by GMR-hid.  Though interesting in its own 
right, this result in fact argues that CG11870 is not related to the suppressor 
phenotype of Su(21-3s).  For this to be the case, two improbable scenarios 
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would have to be invoked.  First, the insertion in Su(21-3s) flies, which falls 
within an internal intron of CG11870, not upstream or within the first intron 
(Fig. 2), would have to be a strong gain-of-function mutation that 
significantly increases CG11870 expression to a level comparable to that 
achieved by GMR transgenes.  Second, given the results of the northern 
analysis, this considerable increase in expression would have to be restricted 
to a pre-adult stage.  Finally, Su(21-3s) is a potent endogenous suppressor of 
GMR-hid, whereas strong transgenic overexpression of CG11870 gives only 
a moderate suppression.  Taken together, these data compellingly indicate 
that the insertion identified in Su(21-3s) flies does not give rise to the 
observed suppressor phenotypes and that another gene is responsible.  As is 
described in the next chapter, this indeed turned out to be the case. 
 
Experimental Procedures 
Fly stocks and genetics 
 The following fly stocks were used for the dominant modifier screens: 
GMR-rpr81 (White et al., 1996), GMR-rpr34 Cyo/Sco (Bergmann et al., 
1998), GMR-hid10 and hs-hid3 (Grether et al., 1995), GMR-grim (Chen et al., 
1996), GMR-phyl (Chang et al., 1995), GMR-rho1 (Hariharan et al., 1995), 
vg-Gal4 (F.M. Hoffmann, unpublished), UAS-hid (Zhou et al., 1997).  
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Stocks for meiotic recombination mapping (ru1 h1 th1 st1 cu1 sr1 es ca1 and 
ru1 h1 th1 st1 cu1 sr1 es Pr1 ca1/TM6B, Bri1, Tb1) and GMR-Gal4 were 
obtained from the Bloomington Stock Center (Bloomington, IN).  Flies 
carrying GMR-CG11870 and UAS-CG11870 were generated by P element-
mediated transformation according to standard protocols.  All other lines 
were generated by meiotic recombination of the appropriate alleles. 
 Dominant modifier and reversion screens were performed as 
described in Fig. 1 (Agapite, 2002).  Modifiers were mapped to a 
chromosome, balanced and their recessive phenotypes determined.  
Complementation analysis was performed on mutants of the same 
chromosome exhibiting similar recessive phenotypes.  Dominant modifiers 
on the third chromosome were mapped by meiotic recombination using the 
rucuca mapping chromosome.  Male sterility was assessed by mating twenty 
homozygous mutant males individually to Canton-S females.  The mutants 
were considered to display some degree of sterility if fewer than 20% of the 
crosses gave rise to at least forty progeny. 
 All crosses and suppression experiments were carried out at 25°C 
except crosses with vg-Gal4 and UAS-hid, which were performed at both 
18°C and 25°C.  Suppression experiments with hshid were done by heat 
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shocking 1st instar larvae at 37°C for 15 minutes.  Flies were raised on 
standard cornmeal-molasses medium at 25°C unless otherwise indicated. 
   For analysis of gonads, the testes and ovaries of 3-5 day old adult flies 
were dissected into PBS and immediately visualized. Fertility tests were 
performed by placing ten young adult males with five wild-type virgin 
females in a vial at 25°C, and vials were scored for offspring after ten days.  
Flies were raised on standard cornmeal-molasses medium. 
 
Identification of a polymorphism in the Su(21-3s) mutant 
 The 2Kb polymorphism in Su(21-3s) flies was identified as previously 
described (Agapite, 2002).  Briefly, the dominant suppressor phenotype 
associated with Su(21-3s) was roughly mapped by meiotic recombination to 
the right arm of the 3rd chromosome near the visible marker, curled.  Dbruce 
mapped to a 74Kb interval in this general area and for this reason Su(21-3s) 
was included in the analysis that led to the cloning of dbruce.  Genomic 
Southern was used to screen this interval using individual EcoR1 fragments 
as probes.  One fragment revealed a polymorphism in Su(21-3s) relative to 
wild-type and was partially sequenced.  PCR using primer pairs designed to 
give 1 Kb products that spanned this fragment was performed with both 
wildtype and Su(21-3s) genomic DNA and one primer pair yielded a 1Kb 
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product from wildtype and a 3Kb product from Su(21-3s) templates.  These 
products were sequenced and revealed that Su(21-3s) contained an insertion 
in the third intron of the predicted gene CG11870. 
 
Molecular Biology 
 A full length cDNA clone encoding the long isoform of CG11870 was 
obtained from the Drosophila Genomics Resource Center (clone ID: 
GM10858) and the entire ORF was subcloned into the pUAST (Brand and 
Perrimon, 1993), pGMR (Hay et al., 1994) and pSPT18 (Roche) vectors to 
generate pUAST-CG11870, pGMR-CG11870 and pSPT18-CG11870, 
respectively.  Plasmid DNA for each construct was isolated using the Qiagen 
Plasmid Maxi Prep kit (Qiagen). 
 For Northern analysis total RNA was extracted from 100 adult yw and 
Su(21-3s) flies using the TRIZOL reagent according to the manufacturer's 
instructions (Invitrogen).  Northern analysis was performed by using 1ug of 
total RNA per sample and blotting with a DIG-labeled RNA probe 
complimentary to the last 300bp of CG11870 coding sequence according to 
the Dig-Northern Starter Kit (Roche).  Probes were prepared with 1ug of 
linearized pSPT18-CG11870 DNA and SP6 RNA polymerase using the DIG 
RNA Labeling Kit (Roche). 
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CHAPTER 3. 
Molecular and Biochemical Analysis of ras1R68Q, a Viable Gain of 
Function Mutation in the Switch II Region of Drosophila ras1. 
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Summary 
Cells are continuously exposed to a multitude of environmental cues and are 
required to integrate the resulting signals into cell fate decisions, including 
whether to live or die.  Among the many signaling pathways that control 
these fate decision, mitogen-activated protein kinase (MAPK) family 
members are crucial for the transduction of signals that mediate survival, 
proliferation and differentiation.  This evolutionarily conserved pathway can 
respond to a number of extracellular inputs, such as growth factors, to 
promote cell survival by inhibiting the activation of apoptosis.  A central 
regulator of these signal transduction processes is the small GTPase Ras, 
which is involved in virtually every aspect of cell biology.  The critical 
nature of Ras in physiologic homeostasis is underscored by the fact ~20% of 
all human tumours contain an activating mutation in one the Ras genes.   
Much of our understanding of the role Ras proteins play in development has 
come from studies in genetic systems such as the developing Drosophila eye 
C. elegans vulva.  Here we report the identification and characterization of a 
novel gain-of-function mutation in the switch II region of RAS85D (ras1), 
the Drosophila homologue of mammalian N-ras, K-ras and H-ras.  Though 
several loss of function alleles have been described for drosophila ras1, this 
mutation represents the first endogenous ras1 hypermorph to be isolated. 
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Introduction 
 The development of multicellular organisms requires the tight 
coordination of cell proliferation, cell differentiation and cell death in order 
to correctly specify cell fate and number.  One model that describes how this 
can be achieved is the trophic theory of survival.  Originally postulated to 
explain the massive neuronal cell loss during development of the vertebrate 
CNS, the trophic theory presumes that in the absence of extracellular 
survival factors, cells die by the engagement of a default cell death program.  
Cells compete for these trophic factors, secreted from neighboring cells in a 
limited amount, thereby ensuring that only an appropriate number survive 
(Raff, 1992).  This ‘social control’ of cell survival ensures the integrity of 
tissues by matching the correct number of different cell types to each other. 
 The MAPK pathway is one of many conserved signaling modules that 
respond to extracellular cues and relay survival signals to the cell interior.  
The signaling relay consists of a transmembrane receptor that binds to 
extracellular factors, intracellular proteins that engage activated receptors 
and amplify the signal and effector molecules that transduce the signal to 
cytoplasmic and nuclear targets.  Signals are propagated via a protein 
phosphorylation cascade by a series of protein kinases which act 
downstream of the small GTPase Ras (Seger and Krebs, 1995). 
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 Ras proteins are guanine nucleotide binding proteins that act as 
molecular switches to integrate the signal transduction pathways involved in 
several aspects of normal cell growth and malignant transformation 
(Colicelli, 2004).  The remarkable fact that ~20% of all human tumours have 
undergone an activating point mutation in one of the Ras genes emphasizes 
the necessity of understanding in detail the mechanistic workings of this 
signal transducer and the biological contexts in which it operates (Bos, 
1989).  Oncogenic mutations in Ras occur most frequently at codons 12,13 
or 61 and result in an enzyme with a deficient GTPase activity that is 
refractory to stimulation by GTPase Activating Protein (GAP) (Scheffzek et 
al., 1997).  Ras thus remains trapped in an active state because Ras is ‘on’ 
when bound to GTP and is switched ‘off’ by hydrolyzing bound GTP to 
GDP.  Inhibition of Ras GTPase activity therefore stabilizes Ras in its active 
conformation, prolonging its recruitment and activation of downstream 
signaling components. 
 Much of our understanding of Ras-mediated signaling is derived from 
a combination of biochemical experiments conducted in mammalian tissue 
culture and screens conducted in the workhorses of developmental genetics, 
Drosophila melanogaster and Caenorhabditis elegans (McCormick, 1994).  
For example, the power of Drosophila genetics proved instrumental in 
 100 
defining how Ras-mediated signaling regulates the specification and 
differentiation of R7 photoreceptors in the fly eye (Gaul et al., 1992; Rebay 
et al., 2000; Simon et al., 1991).  Furthermore, findings from the genetic 
screens described in the previous chapter and from those conducted by 
others, have defined a mechanism by which Ras-mediated signaling can 
directly inactivate a critical component of the intrinsic cell death pathway 
(Bergmann et al., 1998; Downward, 1998; Kurada and White, 1998).  Such 
successes have helped to garner credibility and visibility for Drosophila as a 
model organism in cancer research (Vidal and Cagan, 2006). 
 In Drosophila, ras85D (ras1) is the ortholog of mammalian H-ras, K-
ras and N-ras (Neuman-Silberberg et al., 1984).  As a complimentary 
approach to the use of genetic screens, Ras has also been extensively studied 
in Drosophila by targeted overexpression of activated Ras alleles in a variety 
of tissues and paradigms.   For example,  ras1V12 has been expressed in 
imaginal discs and larval hemocytes to examine cell proliferation, 
differentiation and cell death (Asha et al., 2003; Fortini et al., 1992; Karim 
and Rubin, 1998).  The use of such transgenic approaches in Drosophila has 
helped to elucidate the role of Ras in a variety of signaling pathways and 
developmental contexts. 
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 In the previous chapter, we described the isolation and preliminary 
phenotypic characterization of the Drosophila mutant Su(21-3s).  This 
mutant was identified as a dominant suppressor of GMR-hid induced cell 
death in a genetic modifier screen.  Here we report on the further 
characterization of Su(21-3s) and show that its associated suppressor 
phenotypes derive from a hypermorphic mutation of ras1.  Though 
numerous loss of function alleles have been described for ras1, the mutation 
described here represents the first endogenous gain of function allele to be 
identified.  The phenotypic consequences of this hypermorph in various 
developmental contexts is investigated. 
 
Results 
Phenotypic characterization of Su(21-3s) 
 As stated in the previous chapter, we sought to re-examine more 
rigorously the suppression phenotypes of Su(21-3s) in the eye by testing the 
modifier effects of one or two copies of Su(21-3s) against various GMR 
expression constructs (Fig. 1).  This analysis confirmed unequivocally that 
Su(21-3s) potently suppresses GMR-hid induced cell death in a dosage 
dependent manner (Fig. 1A,B).  Unexpectedly, however, we found the 
suppression of GMR-rpr and GMR-grim phenotypes, though detectable as  
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Fig. 3.1.  GMR-hid but not GMR-grim or GMR-rpr induced cell death is 
dominantly suppressed by Su(21-3s) in a manner that requires intact MAPK 
phosphorylation sites in hid.  (A-F) GMR driven expression of IAP-
antagonist induces cell death in the eye.  Cell death is strongly suppressed by 
one (′) or two (′′) copies of the Su(21-3s) chromosome when induced by 
either a weak allele, GMR-hid1M (A) or strong allele, GMR-hid10 (B) of hid, 
but is very weakly suppressed by Su(21-3s) when induced GMR-grim (E) or 
GMR-rpr (F).  In addition, Su(21-3s) suppresses cell death induced by a hid 
allele lacking 3 of 5 predicted MAPK phosphorylation sites, GMR-hidAla3 (C) 
but not by GMR-hidAla5 (D), a hid allele lacking all 5 MAPK consensus. sites 
(Bergmann et al., 1998).  (G-H) Death of larval hemocytes induced by 
expression of hid under control of the hemocyte specific driver Hml is also 
partially suppressed by the Su(21-3s) mutation.  (G) EGFP is used to 
visualize hemocytes in wildtype 3rd instar larva: Hml-GAL4, 2xUAS-EGFP.  
(H) Overexpression of Hid in hemocytes results in their complete ablation 
by the 1st instar larval stage: Hml-Gal4, 2xUAS-EGFP; UAS-hid.  (I) Su(21-
3s) is able to partially suppress hemocyte death induced by HID.  Surviving 
hemocytes appear to be concentrated within the lymph glands: Hml-Gal4, 
2xUAS-EGFP; UAS-hid, Su(21-3s).  Genotypes are as indicated except 21-
3s refers to Su(21-3s). 
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initially reported in the screen, to be extremely weak, even in the presence of 
two copies of Su(21-3s) (Fig. 1E,F).  Given that hid is highly expressed in 
the developing eye, we believe the small effect exerted by Su(21-3s) on 
GMR-rpr and GMR-grim is due to a suppression of endogenous Hid activity 
and not on Rpr or Grim (Grether et al., 1995).  We therefore conclude that 
Su(21-3s) is a hid specific suppressor that again illustrates a distinction 
between the hid, grim and rpr pathways. 
 It has been demonstrated that Hid activity is regulated by the 
EGFR/MAPK pathway in a manner that depends on intact MAPK 
phosphorylation sites in Hid.  Intriguingly, our analysis here reveals that 
Su(21-3s) readily suppresses GMR-hidAla3, a hid allele lacking 3 of 5 
predicted MAPK phosphorylation sites, but fails to suppress GMR-hidAla5, 
which is missing all 5 MAPK sites (Fig. 1C,D) (Bergmann et al., 1998).  
This requirement for one or two of the predicted MAPK phosphorylation 
sites in Hid (Ser-121 and Thr-228) suggested that Su(21-3s) might be 
mediating its suppressive effects through the EGFR/MAPK pathway. 
 We further extended analysis of the Su(21-3s) suppression phenotype 
to the developmental context of larval hemocytes, an important model 
system for the study of vertebrate haematopoiesis (Jung et al., 2005; Wood 
and Jacinto, 2007).  Drosophila hemocytes require trophic signaling from 
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multiple pathways for their survival and in its absence undergo caspase 
dependent cell death (Bruckner et al., 2004; Matova and Anderson, 2006).  
Using a hemocyte specific promoter to drive expression of EGFP, we 
visualized hemocytes in wandering 3rd instar larva (Fig. 1G) (Goto et al., 
2003).  Ectopically expressing Hid using the same driver results in complete 
ablation of hemocytes by the 1st instar larval stage (Fig. 1H).  Su(21-3s) is 
able to partially suppress this cell death such that anterior hemocyte 
aggregates become readily visible, possibly due to “cannibalistic 
phagocytosis” by surviving hemocytes as described by Bruckner et al (Fig. 
1I). 
 
Su(21-3s) is a gain-of-function allele of ras85D (ras1) 
 In order to identify the gene responsible for the Su(21-3s) phenotype, 
we mapped it by a second, finer round of meiotic recombination to a 1 Mb 
interval between 85A and 85E, then further localized the mutation by P-
element mediated male recombination to a 270 Kb interval between 85D11 
and 85E1 (Fig. 2A).  Given that Su(21-3s) differentially suppresses hid, but 
not grim or rpr in a manner reminiscent of EGFR/MAPK mutants, we 
suspected that Su(21-3s) might be a hypermorphic allele of ras85D(ras1), 
which is located within this interval.  Therefore, we sequenced ras1 in a 
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Fig. 3.2.  Su(21-3s) is a gain of function allele of ras85D(ras1), the 
Drosophila ortholog of human N-ras, H-ras and K-ras.  (A) The cell death 
suppression phenotype of Su(21-3s) mutants was mapped by meiotic 
recombination to the region of the 3rd chromosome indicated by the large 
horizontal arrow.  This interval was further narrowed by P-element induced 
male recombination mapping to the region indicated by the short arrow.  
This shorter interval corresponds to 5.162-5.452 Mb on the physical map 
and an enlargement of this interval is shown below indicating the ORFs 
contained therein, including ras85D or ras1, outlined with a red box.  The 
ras85D locus was subsequently sequenced in a candidate gene approach and 
a G to A transition in exon3 was identified.  This transition results in an 
amino acid substitution at position 68 of the ras1 protein (Ras1R68Q.)  (B) 
Amino acid alignment of the universally conserved Switch II region of Ras. 
The Su(21-3s) mutation is highlighted in yellow.  (C) Schematic diagram of 
the Ras protein highlighting conserved functional regions as well as some 
well known naturally occurring activating point mutations that inhibit GTP 
hydrolysis and therefore lock the GTP-RAS complex in an active form.  The 
Switch regions are known to undergo large conformational changes upon 
exchange of bound GDP for GTP (Souhami, 2002).  Numbers indicate 
amino acid position.  HVR, hypervariable region. 
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candidate gene approach and a G to A transition in exon3 was identified.  
This transition mutation results in an amino acid substitution at position 68 
of the Ras1 protein, replacing a positively charged arginine within the 
universally conserved Switch II region of Ras1 with a neutral glutamine 
(Fig. 2B).  The switch regions of Ras have been defined as regions that 
undergo a large conformational change upon transition from the GTP- to the 
GDP-bound state (Milburn et al., 1990).  Detailed crystal structures have 
revealed that residues in the Switch II region of Ras contact and are 
stabilized by GAP, allowing them to participate in the catalysis of GTP 
(Scheffzek et al., 1997).  Mutations in the Switch II may therefore interfere 
with Ras GTPase activity and possibly explains why several naturally 
occurring oncogenic Ras mutations occur in this area (Fig. 2C) (Brose et al., 
2002; Lee et al., 2003).  It therefore seemed feasible that the R68Q mutation 
identified in Su(21-3s) flies could similarly result in a Ras protein with 
enhanced signaling capacity. 
 We reasoned that if the Su(21-3s) phenotype is due to a gain of 
function mutation in ras1, it should be revertible by introduction of a 
second, intragenic loss of function mutation.  To test this, we conducted a 
reversion screen for loss of the Su(21-3s) suppression phenotype (Fig. 3A).  
From a total of 80,000 F1 progeny that were screened, 15 phenotypic 
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revertants were recovered.  Based on lethality, 11 of these could be placed 
into one of 4 complementation groups.  One of these groups, containing the 
revertants Su(21-3s)R11 and Su(21-3s)41, failed to complement the lethal null 
ras85De1B allele and therefore corresponds to the ras85D (ras1) locus.  
Analysis of these two revertants revealed intragenic loss-of-function 
mutations in the ras1 coding sequence (Fig. 3F).  One revertant contains a 
31bp deletion in ras1 that results in a Ras1 protein truncated at amino acid 
87.  The second revertant contains an in frame 18bp deletion of ras1 that 
eliminates amino acids 87-92 of the protein, which are known to be essential 
for Ras function (Willumsen et al., 1986).  These revertants greatly resemble 
the null ras85De1B or ras85De2F alleles with regard to suppression of GMR-
hid and lethality (Fig. 3B-E and data not shown) and provide genetic 
evidence for the hypothesis that Su(21-3s) is due to a revertible gain-of-
function mutation in ras1. 
 Finally, as an allele of ras1, Su(21-3s) should interact genetically with 
other members of the MAPK signaling pathway in a predictable manner.  
We crossed GMR-hid10 flies in a Su(21-3s) background to mutants of MAPK 
signaling and observed the extent of cell death in the eye (Fig. 4).  MAPK 
signaling mutants tested include argos, ras1, rolled and EGFR.  In this 
analysis, the Su(21-3s) mutant behaves as expected for a gain-of-function  
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Fig. 3.3.  Screen to revert the Su(21-3s) suppressor phenotype.  A) 
Homozygous Su(21-3s) males were treated with 4000 rad x-rays and crossed 
to GMR-hid1M; Sb/TM6B females.  80,000 F1 progeny were screened for 
loss of the Su(21-3s) suppression phenotype.  A total of 15 phenotypic 
revertants were recovered, 11 of which could be placed into one of 4 
complementation groups.  One of these groups, containing revertants Su(21-
3s)R11 and Su(21-3s)41, corresponds to the ras85D (ras1) locus.  (B-E) The 
suppression of the GMR-hid10 rough eye phenotype (B) by the Su(21-3s) 
mutation (C) is lost in revertants Su(21-3s)R11 (D) and Su(21-3s)R41(E).  
Genotypes: (B) GMR-hid10/+, (C) GMR-hid10/+;Su(21-3s)/+ (D) GMR-
hid10/+;Su(21-3s)R11/+ and (E) GMR-hid10/+;Su(21-3s)R41/+.  F)  A schematic 
of the ras85D locus with exons boxed and coding regions stippled, depicting 
the relative locations of  the Su(21-3s) point mutation in exon 3 to the 
deletions identified in Su(21-3s)R11 and Su(21-3s)R41 (labeled R11 and R41 
respectively).  The red arrows correspond to PCR primers used in a 
diagnostic for the Su(21-3s) point mutation.  As illustrated by the sequence 
alignments below, Su(21-3s)R41 contains a 31bp deletion compared to the 
wildtype ras85D locus, resulting in a frameshift at amino acid 6 and a 
truncation amino acid 87.  The Su(21-3s)R11 mutant contains an 18bp in 
frame deletion that removes amino acids 87-92.  Sequences are labeled on 
the left and numbers above correspond to basepair position in the ras1 
cDNA.  Also shown is a PCR diagnostic confirming that Su(21-3s)R11 (R11) 
and Su(21-3s)41 (R41) retain the Su(21-3s) point mutation. 
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ras1 allele. For example, Su(21-3s) is not much affected by loss-of-function 
mutations in upstream components of MAPK signaling, such as argos or 
EGFR (Fig. 4B,C), but is strongly ameliorated by loss of downstream 
components, such as rolled (Fig. 4E).  Additionally, when a dominant 
negative form of Ras1 (sev-ras1N17) is expressed in the eye, the suppressive 
effects of Su(21-3s) are severely abrogated.  Taken together, these data 
confirm that Su(21-3s) is an allele of ras1 and we refer to Su(21-3s) from 
here on as ras1R68Q. 
 
Biochemical analysis of recombinant Ras1R68Q 
 To test the hypothesis that exchanging a positively charged arginine 
with a neutral glutamine at position 68 of Ras1 results in a protein with a 
deficient GTPase activity, the intrinsic GTPase rates of wildtype and mutant 
Ras1 proteins were compared (Fig. 5).  Full length wildtype Ras1 and 
mutant Ras1R68Q proteins were bacterially expressed and purified as His-
tagged fusion proteins, yielding large amounts of pure, catalytically active 
enzyme.  Intrinsic GTPase activity was measured with a kinetic phosphate 
assay employing [γ-33P]GTP as substrate.  This sensitive assay revealed that 
Ras1R68Q has an intrinsic GTPase activity that is approximately 1/3 that of 
wildtype Ras1, with enzymatic rates (kcat) of 0.020 min-1 and 0.063 min-1,  
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Fig. 3.4.   The Su(21-3s)/ras1R68Q mutant differentially interacts with 
components of the EGFR/MAPK pathway.  Suppression of the GMR-hid10 
induced eye ablation phenotype by Su(21-3s) (A vs A’) is not much affected 
by loss of function mutations in upstream components of MAPK signaling 
such as argos (B vs B’) or egfr (C vs C’), but is strongly ameliorated by loss 
of downstream components, such as rolled (A’ vs E’).  Additionally, when a 
dominant negative form of Ras1 (sev-ras1N17) is expressed in the eye, the 
suppressive effects of su(21-3s) are completely abrogated (A’ vs D’).  
Genotypes are as indicated except that 21-3s refers to Su(21-3s)/ras1R68Q 
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Fig. 3.5.  Structural and biochemical analysis of wildtype and mutant Ras1.  
(A-B) Three-dimensional crystal structure of human H-Ras (pink) bound to 
the GTPase-activating domain of human GTPase-activating protein p120GAP 
(GAP-334, blue) in the presence of aluminum fluoride (AlF3, green.)  The 
positions of oncogenic residues glycine-12 (G12) and glutamine-61 (Q61) as 
well as the mutant residue in ras1R68Q flies, arginine-68 (R68), are shown in 
yellow.  The Switch II region of Ras, of which Q61 and R68 are a part, is 
stabilized by GAP-334.  (B) An enlargement of (A) showing the finger loop 
of GAP-334, which supplies an arginine side chain (arginine-789) into the 
active site of Ras to neutralize developing charges in the transition state 
(Scheffzek et al., 1997).  R68, located proximally to the catalytic site of Ras, 
also extends a positively charged guanidinium group towards the active site.  
The images were constructed using the Entrez software Cn3D with 
mmdbId:51925 (Chen et al., 2003).  Guanosine diphosphate (GDP,brown); 
Mg2+ (grey).  (C) The intrinsic GTPase activities of affinity purified 
drosophila Ras1wt (blue) and Ras1R68Q (black) were determined using a 
kinetic phosphate assay employing [γ-33P]GTP as a substrate.  The 
conditions of the assay are such that the reaction proceeds with unimolecular 
kinetics and is insensitive to the amount of Ras protein employed (dashed vs. 
undashed lines).  The mutant Ras1R68Q has an intrinsic GTPase activity that 
is approximately 1/3 that of wildtype Ras1 (kcat= 0.020 min-1 and 0.063 min-1 
respectively.) (D) Human GAP-285 protein was purified by affinity 
chromatography and its ability to stimulate wildtype and mutant Ras1 
proteins was tested using a real-time fluorescent assay.  Ras1R68Q is 
amenable to GAP stimulation, but to a lesser extent than is the wildtype 
Ras1 protein.  Data is the average of three independent experiments.  Error 
bars are in red.  E) Typical intrinsic GTPase rates.  
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respectively (Fig. 5C).  This supports the prediction that the gain of function 
nature of Ras1R68Q is due to a reduced GTPase activity.  Additionally, since 
many activating Ras mutations result in an enzyme that is insensitive to 
GAPs, the ability of Ras1R68Q to be stimulated by GAP was also assessed.  
Recombinant human GAP-285 protein was purified by affinity 
chromatography and its ability to stimulate wildtype and mutant Ras1 
proteins was tested using a sensitive real-time fluorescent assay.  It was 
determined that Ras1R68Q remains amenable to GAP stimulation, although to 
a lesser extent than the wildtype Ras1 protein (Fig. 5D).  Unlike the 
oncogenic, constitutively active mutant Ras1V12, whose GTPase activity is 
completely refractory to stimulation by GAP, Ras1R68Q  can be regulated by 
GAP and is able to cycle between on and off states (Trahey and McCormick, 
1987).  This biochemical data supports the hypothesis that Ras1R68Q has a 
reduced GTPase activity, remains in its active GTP-bound form for a 
prolonged period of time and therefore has an enhanced signaling capacity, 
but is still largely amenable to regulation, permitting nearly normal cellular 
function and organismal development. 
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Analysis of midline glia (MG) survival in ras1R68Q embryos 
 Drosophila midline glia (MG) cell survival during embryonic 
development is exquisitely sensitive to MAPK activity levels (Bergmann et 
al., 2002; Stemerdink and Jacobs, 1997).  During formation of the 
Drosophila central nervous system, there are initially about ten MG cells per 
segment at stage 13.  Most of these undergo apoptosis in a rpr, hid and grim 
dependent manner such that by stage 17, only three MG per segment survive 
(Sonnenfeld and Jacobs, 1995; Zhou et al., 1997).  We tested the effect of 
ras1R68Q in this sensitive system.  MG cells were visualized in wildtype and 
ras1R68Q embryos using the MG-specific reporter fusion construct pslit-lacZ 
and β-gal immunohistochemistry and clearly marked MG cells were 
carefully counted.  This analysis revealed an increase in the number of MG 
cells in ras1R68Q embryos as compared to wildtype embryos (Fig. 6A,B).  
Stage 17 wildtype embryos contained an average of 2.8 MG cells per 
segment (n=448) whereas ras1R68Q embryos contained an average of 3.3 MG 
cells per segment (n=420).  This difference is statistically significant by an 
unpaired t-test (p95≤0.0001) and is consistent with elevated MAPK survival 
signaling in ras1R68Q flies (Fig. 6C). 
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Fig. 3.6.  Ras1R68Q mutant embryos contain extra midline glial (MG) cells.   
MG were visualized in wildtype (A) and ras1R68Q (B) stage 17 embryos 
using the MG-specific reporter construct P[slit-1.0-lacZ] and β-gal 
immunohistochemistry.  During development, the majority of MG undergo 
apoptosis such that at this stage only about three MG per segment normally 
survive.  This analysis reveals an increase in the number of surviving MG 
cells in ras1R68Q embryos as compared to wildtype embryos.  Arrows 
indicate segments that clearly contain more than three MG cells.  (C) 
Wildtype embryos contained an average of 2.8 MG cells per segment 
(n=448) whereas ras1R68Q embryos contained an average of 3.3 MG cells per 
segment (n=420).  This difference is statistically significant by an unpaired 
t-test (p95≤0.0001) and is consistent with enhanced MAPK signaling in 
ras1R68Q mutants. 
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Assay for supernumery R7 cells in ras1R68Q adult eyes 
 The adult Drosophila eye comprises about 800 ommatidia, each with a 
precise, reproducible structure consisting of eight photoreceptors and 12 
accessory cells (Cagan and Ready, 1989; Morante et al., 2007; Tomlinson, 
1988).  Adoption of a neuronal cell fate by the precursor cell of R7 
photoreceptors requires an inductive signal from the neighboring R8 cell and 
is dependent on EGFR/MAPK signaling (Gaul et al., 1992; Simon et al., 
1991; Yang and Baker, 2001).  In addition, cone cell precursors are capable 
of acquiring an R7 cell fate if MAPK signaling is ectopically activated in 
these cells, resulting in extra R7 cells that are easily visualized (Fortini et al., 
1992).  To determine if the ras1R68Q mutation exerts effects in a paradigm 
other than apoptosis, such as cell fate determination, semi-thin plastic 
sections of adult eyes were prepared and analyzed for defects in ommatidia 
formation.  This analysis revealed two clear defects in ras1R68Q flies that are 
typical for mutations that enhance RAS/MAPK signaling during eye 
development.  First, we detected ommatidia with supernumery R7 cells 
indicating that the ras1R68Q mutation can provide a sufficiently strong 
inductive signal to drive cone cell precursors towards an R7 photoreceptor 
fate (Fig. 7B).  Second, we observed ommatidia missing an occasional outer 
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Fig. 3.7.  Developmental analysis of the ras1R68Q mutant adult eye 
phenotype.  To determine if ras1R68Q exhibits phenotypes in a paradigm other 
than apoptosis, semi-thin plastic sections of adult eyes were prepared and 
analyzed for defects in ommatidia formation.  (A) Wildtype ommatidia 
contain one R7 cell and six outer photoreceptor cells.  (B-C) Ras1R68Q flies 
contain two types of differentiation defects typical of mutations that increase 
RAS/MAPK signaling during eye development, including supernumery R7 
cells (arrowhead inside red outline, B) and missing outer photoreceptor cells 
(arrow, C).  The developmental defects in retinal cell differentiation 
observed here supports our hypothesis that flies carry a gain of function ras1 
allele.  The schematic illustrates the major cell types present in the 
ommatidia 
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photoreceptor cell, also reported to be a phenotypic consequence of elevated 
MAPK signaling (Fig. 7C) (Fortini et al., 1992).  
 
The wings of ras1R68Q flies contain ectopic vein material 
 In addition to defects in the eye and midline glial cells, ras1R68Q flies 
also show abnormalities in adult wing tissues.  Homozygous ras1R68Q flies 
contain an additional longitudinal “veinlet” seen to branch off the posterior 
crossvein (Fig. 8).  Additionly, an ectopic longitudinal vein appears directly 
beneath the posterior crossvein and an ectopic crossvein appears between the 
L4 and L5 wing veins near the hinge (Fig. 8B,F).  These phenotypic defects 
are remarkably similar to those observed in the wings of rlsem and DEREllipse 
flies which exhibit elevated levels of MAPK signaling in the wing as they 
are hypermorphic alleles (Brunner et al., 1994).  When UAS-ras1R68Q is 
overexpressed in the wing using en-Gal4 an extensive amount of ectopic 
wing vein material develops and blisters also commonly appear (Fig. 8D).  
Overexpression of wildtype Ras1 in the same manner results in a significant 
but less severe phenotype (Fig. 8C).  We also attempted to express the 
ras1V12 mutant in the wing using en-Gal4 but found this induced lethality, a 
problematic feature of this ras1 allele. 
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Fig. 3.8.  Wing phenotypes associated with the ras1R68Q allele.  Flies bearing 
the ras1R68Q allele develop ectopic wing material including extra longitudinal 
‘veinlets’ near the posterior crossvein (arrows, B) and an extra crossvein 
near the wing hinge (red box, B and arrow, F).  Overexpression of either 
wildtype ras1 (C) or ras1R68Q (D) using the en-Gal4 driver results in the 
deposition of substantial amounts of ectopic vein material.  (E,F) 
Magnification of (A) and (B) encompassing the area boxed in red.  The 
arrow in (F) indicates an ectopic crossvein observed in ras1R68Q flies.  
Genotypes are as indicated.  ACV, anterior crossvein. L5, L5 wing vein.  
Anterior is up. 
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Overexpression in the eye of ras1R68Q, but not wildtype ras1, induces 
severe overgrowth defects 
 To further establish that Ras1R68Q is an activated version of the Ras1 
protein and to observe the phenotypic consequence, we ectopically 
 expressed ras1R68Q in the developing Drosophila eye.  Overexpression of 
wildtype Ras1 in various Drosophila tissues, even at the high levels obtained 
by transgene expression, often results in mild or no observable phenotypic 
effect (Fortini et al., 1992).  For this reason, studies of elevated Ras1 
signaling in Drosophila largely rely on a constitutively active, non-
regulatable ras1V12 mutant allele.  We similarly observed in eleven 
independent transgenic lines that wildtype UAS-ras1 expression driven by 
GMR-Gal4 was fully viable and had only minor effects on eye development 
(Fig. 9B).  In sharp contrast, expression of UAS-ras1R68Q in seven 
independent transgenic lines resulted in lethality for three and highly 
distorted eyes that appear to exhibit both overgrowth and cell death 
phenotypes for the remaining four (Fig. 9C-F).   Similar results were 
obtained using sev-Gal4 to drive ras expression (Fig. 9G,H).  Interestingly, 
the anterior part of the eye appears to be much more sensitive to ras 
expression by the sev-Gal4 driver since overgrowth is largely restricted to 
this region. 
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Fig. 3.9.  Overexpression of ras in the eye induces developmental defects 
causing both overgrowth and cell death phenotypes.  Flies overexpressing 
wildtype ras1 (B,G) exhibit relatively minor disruptions in eye patterning 
and in the case of sev-Gal4 driven expression, a small but significant amount 
of overgrowth occurs in the anterior part of the eye (G).  In contrast, 
overexpression of ras1R68Q with GMR-Gal4 (C-F) causes severe overgrowth 
and patterning disruptions.  An example from each of four independent 
transgenic lines is shown to illustrate the range of phenotypes.  Likewise, 
overexpression of ras1R68Q with sev-Gal4 elicits a much more pronounced 
overgrowth phenotype in the anterior part of the eye (H) compared to that of 
wildtype ras1 (G).  Genotypes: (A) GMR-Gal4/+, (B) GMR-Gal4/+;UAS-
ras1/+, (C-F) GMR-Gal4/+;UAS-ras1R68Q/+, (G) sev-Gal4/+;UAS-ras1/+, 
(H) sev-Gal4/+;UAS-ras1R68Q/+. 
 125 
For purposes of comparison we attempted to express two different 
UAS-ras1V12 alleles in the eye with both these drivers, but unsurprisingly, 
again found this induced lethality (likely due to leaky expression and the fact 
that ras1V12 can elicit non-cell autonomous death when overexpressed) 
(Karim and Rubin, 1998).  These overexpression experiments further 
support the notion that Ras1R68Q is an activated Ras protein that, in contrast 
to the constitutively active Ras1V12 protein, remains amenable to negative 
regulation and therefore is less biologically potent than Ras1V12.  All else 
being equal, this will permit overexpression of the ras1R68Q allele with a 
broader array of transgenic promoters in a wider range of physiologic 
contexts. 
 
Discussion 
 The work presented here encompasses a genetic, molecular and 
biochemical characterization of the first endogenous gain-of-function ras1 
mutation to be identified in Drosophila.  This hypermorphic Ras allele, 
Ras1R68Q, ranks among one of a very few viable Ras hypermorphs to be 
identified in any multicellular organism.  A curious fact considering the 
hundreds and perhaps thousands of genetic screens carried out over the last 
two decades or so with the express purpose of identifying components in the 
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Ras/MAPK signaling pathway.  In fact, only two viable gain-of-function 
mutations in an essential Ras gene are well known, both of which are alleles 
of the C. elegans Ras homolog let-60 (Sternberg and Han, 1998).  One of 
these alleles, let-60(G13E gf), has been independently isolated more than 5 
times and when taken into account with the countless loss-of-function and 
dominant negative Ras alleles that have been isolated across the animal 
kingdom, it is clear that the Ras locus has been well saturated in mutagenesis 
experiments.  It appears that hypermorphs of Ras are very poorly tolerated in 
biological systems and likely reflects the critical and ubiquitous role played 
by Ras in biological systems. 
 Of course, many lethal gain-of-function Ras mutations have been 
identified, particularly in the context of human tumorigenesis.  An activating 
mutation in one of the three human ras genes is found in ~20-30% of all 
tumours, and in up to 90% of some types of carcinomas (Bos, 1989).  
Invariably these oncogenic mutations occur at amino acid positions 12,13 or 
61 and result in a very potent, constitutively active Ras protein.  Normally, 
Ras proteins cycle between a GTP-bound state in which they able to 
productively engage downstream effectors and a GDP-bound state in which 
they are inactive.  The interconversion between these two states is tightly 
regulated by two classes of enzymes: guanine nucleotide exchange factors 
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(GEFs) which catalyze the exchange of GDP for GTP thereby activating 
Ras, and GTPase activating enzymes (GAPs) which inactivate Ras by 
dramatically stimulating the rate of GTP hydrolysis by Ras.  Like Ras, these 
regulatory proteins are highly conserved throughout many species (Colicelli, 
2004). 
 In Drosophila, Ras1 has been implicated in  a number of 
developmental processes,  including the specification of ventral ectoderm 
fate in the embryo, imaginal disc cell growth, differentiation of wing vein 
and photoreceptor cells and regulation of embryonic midline glia survival by 
suppression of apoptosis (Bergmann et al., 2002; Diaz-Benjumea and Hafen, 
1994; Miller and Cagan, 1998; O'Keefe et al., 2007; Yang and Baker, 2001).  
Genetic analysis in Drosophila has been pivotal in delineating the many 
functions of Ras during development and pathogenesis and many of the 
insights gleaned from these studies have proven applicable to other 
organisms, including humans. 
 We have described the isolation and characterization of Ras1R68Q, a 
viable gain-of-function Ras allele that contains a mutation in the universally 
conserved Switch II region.  Initially identified as a dominant suppressor of 
hid induced cell death in the eye, we extended the characterization of its 
suppression phenotype to larval hemocytes and in the setting of other MAPK 
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pathway mutants.  Moreover, we describe the phenotypic consequences of 
this gain-of-function allele in several developmental contexts including its 
effect on midline glia survival in embryos, R7 photoreceptor differentiation 
in ommatidia and wing vein development.  Finally, we showed 
biochemically that this Ras1 allele has a reduced intrinsic GTPase activity of 
about one third that of wildtype Ras1, but that it remains responsive to GAP 
stimulation.  This latter fact is almost certainly why Ras1R68Q is viable. 
 
Experimental Procedures 
Fly stocks and genetics 
 The following fly stocks were used: GMR-rpr81 (White et al., 1996), 
GMR-hid1M, GMR-hidAla3 and GMR-hidAla5 (Bergmann et al., 1998), GMR-
hid10 (Grether et al., 1995), GMR-grim (Chen et al., 1996), argIΔ7 (Freeman 
et al., 1992), EGFR- = flbf2 (Nussleinvolhard et al., 1984), rl10a (Peverali et 
al., 1996), sev-Ras1N17 (Karim et al., 1996), en-Gal4, sev-Gal4 (Therrien et 
al., 1999), P[slit-1.0-lacZ] (Wharton and Crews, 1993), Hml-Gal4, 2xUAS-
EGFP (J.A. Rodriguez, unpublished).  Stocks for meiotic recombination 
mapping (ru1 h1 th1 st1 cu1 sr1 es ca1 and ru1 h1 th1 st1 cu1 sr1 es Pr1 
ca1/TM6B, Bri1, Tb1) and stocks for P-element induced male recombination 
mapping (y1 w*; CyO, H{PDelta2-3}HoP2.1/Bc1 EgfrE1 as a source of 
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transposase and all P-element insertion lines) were obtained from the 
Bloomington Stock Center (Bloomington, IN).  Flies carrying UAS-ras1 and 
UAS-rasR68Q were generated by P element-mediated transformation 
according to standard protocols.  All other lines were generated by meiotic 
recombination of the appropriate alleles. 
 Su(21-3s) was mapped by meiotic recombination using the rucuca 
mapping chromosome.  Mapping of the Su(21-3s) mutant was further refined 
using P-element induced male recombination with the dominant markers Ly 
and Pr (Chen et al., 1998).  Reversion screens were performed as described 
in Fig. 3.  All crosses and suppression experiments were carried out at 25°C 
except overexpression studies with en-Gal4, GMR-Gal4 and sev-Gal4 used 
in conjunction with UAS-ras1R68Q or UAS-ras1, which were performed at 
18°C. 
 To visualize larval hemocytes, wandering 3rd instar larva expressing 
UAS-EGFP driven by Hml-Gal4 were collected and immobilized on ice 
prior to imaging (Goto et al., 2003).  MG cells in stage 17 embryos were 
visualized using P[slit-1.0-lacZ] and β-gal immunohistochemistry as 
previously described (Patel, 1994).  The number of MG was averaged for 
segments T2 to A5. Tangential sections (1 µm) of adult eyes were prepared 
for analysis of ommatidia (Tomlinson and Ready, 1987). 
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Biochemistry 
 A cDNA clone encoding Drosophila ras1 was obtained from the 
Drosophila Genomics Resource Center (clone ID: RE53955) and the entire 
ras1 ORF was subcloned into pBluescript (Stratagene).  Mutant rasR68Q was 
generated using the QuikChange II XL Site-Directed Mutagenesis Kit 
(Stratagene).  The Ras ORFs were then subcloned into pET-28a (Novagen) 
in frame for an N-terminal His tag for expression and into pUAST (Brand 
and Perrimon, 1993) for P element-mediated transformation.  Catalytic 
human p120-Gap (GAP-285, amino acids 714-998, IMAGE Clone: 
4829173, Open Biosystems) was subcloned into the pET41a vector 
(Novagen)  to generate an N-terminal GST tag.  Fusion proteins were 
expressed in BL21(DE3) E. coli (Invitrogen) and affinity purified on an 
AKTA Purifier (Pharmacia) using a HisTrap FF column (GE Healthcare) for 
Ras proteins and a GSTrap FF column (GE Healthcare) for GAP-285.  Ras 
purification was performed according to the procedure described for human 
H-Ras (Boriack-Sjodin et al., 1998).  GAP-285 was expressed by inducing 
cells for 16 hours at 30°C with 0.2 mM IPTG. 
 Intrinsic GTPase activities were measured using [γ-33P]GTP (3000 
Ci/mmol, NEN) and the EasyRad Phosphate Assay (Cytoskeleton) (Bollag 
and McCormick, 1995).  GAP-stimulated GTPase activities were measured 
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with a real-time assay using the fluorescent substrate MDCC-PBP 
(Invitrogen) and 2 µM Ras protein, with or without, 0.02 µM GAP-285 
(Shutes and Der, 2005). 
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